Gene Symbol | Gene ID | Gene Info |
---|---|---|
Ebf1
|
ENSMUSG00000078561.3 | early B cell factor 1 |
Ebf1
|
ENSMUSG00000057098.8 | early B cell factor 1 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr11_44900591_44900793 | Ebf1 | 11446 | 0.293775 | -0.36 | 6.2e-03 | Click! |
chr11_44925037_44925188 | Ebf1 | 12974 | 0.288877 | 0.35 | 8.9e-03 | Click! |
chr11_44900056_44900207 | Ebf1 | 12007 | 0.292119 | -0.30 | 2.6e-02 | Click! |
chr11_44978191_44978342 | Ebf1 | 66128 | 0.129500 | -0.30 | 2.6e-02 | Click! |
chr11_44977922_44978106 | Ebf1 | 65876 | 0.130078 | -0.29 | 3.4e-02 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr19_5822032_5822731 | 14.93 |
Gm27702 |
predicted gene, 27702 |
2326 |
0.12 |
chrX_53052410_53053563 | 11.36 |
Gm28730 |
predicted gene 28730 |
173 |
0.64 |
chr1_162217277_162218166 | 11.19 |
Dnm3os |
dynamin 3, opposite strand |
2 |
0.57 |
chr7_12010381_12010846 | 10.96 |
Vmn1r-ps60 |
vomeronasal 1 receptor, pseudogene 60 |
5547 |
0.07 |
chr10_127508848_127510720 | 10.90 |
Stac3 |
SH3 and cysteine rich domain 3 |
2559 |
0.15 |
chr3_68493130_68494661 | 10.41 |
Schip1 |
schwannomin interacting protein 1 |
313 |
0.92 |
chr4_152625073_152626079 | 10.29 |
Gm13172 |
predicted gene 13172 |
52427 |
0.14 |
chr15_84639758_84640293 | 10.15 |
Prr5 |
proline rich 5 (renal) |
29595 |
0.16 |
chr5_74905641_74905990 | 9.91 |
Gm17906 |
predicted gene, 17906 |
22480 |
0.17 |
chr14_115040506_115042372 | 9.86 |
Mir17hg |
Mir17 host gene (non-protein coding) |
1440 |
0.19 |
chr11_74896307_74898160 | 9.41 |
Sgsm2 |
small G protein signaling modulator 2 |
173 |
0.84 |
chr11_85829780_85830462 | 9.27 |
2610027K06Rik |
RIKEN cDNA 2610027K06 gene |
2088 |
0.2 |
chr13_97598812_97599432 | 9.00 |
Gm48070 |
predicted gene, 48070 |
10414 |
0.18 |
chr14_32861100_32861956 | 8.92 |
Vstm4 |
V-set and transmembrane domain containing 4 |
4772 |
0.2 |
chr9_97018181_97019319 | 8.85 |
Spsb4 |
splA/ryanodine receptor domain and SOCS box containing 4 |
14 |
0.96 |
chr2_32317120_32318698 | 8.85 |
Gm23363 |
predicted gene, 23363 |
356 |
0.45 |
chr14_34573329_34574596 | 8.49 |
Ldb3 |
LIM domain binding 3 |
3032 |
0.17 |
chr19_10012797_10013296 | 8.47 |
Rab3il1 |
RAB3A interacting protein (rabin3)-like 1 |
1970 |
0.21 |
chr1_85259970_85261058 | 8.34 |
C130026I21Rik |
RIKEN cDNA C130026I21 gene |
1556 |
0.27 |
chr9_44498071_44499796 | 8.34 |
Bcl9l |
B cell CLL/lymphoma 9-like |
203 |
0.84 |
chr19_5071354_5072731 | 8.34 |
Tmem151a |
transmembrane protein 151A |
90 |
0.61 |
chr18_61665433_61665940 | 8.30 |
Carmn |
cardiac mesoderm enhancer-associated non-coding RNA |
149 |
0.92 |
chr19_5023458_5024512 | 8.23 |
Slc29a2 |
solute carrier family 29 (nucleoside transporters), member 2 |
86 |
0.91 |
chr10_3366272_3367238 | 7.94 |
Ppp1r14c |
protein phosphatase 1, regulatory inhibitor subunit 14C |
211 |
0.95 |
chr9_40730616_40731231 | 7.48 |
Gm16095 |
predicted gene 16095 |
10937 |
0.1 |
chr4_123237889_123238202 | 7.31 |
Heyl |
hairy/enhancer-of-split related with YRPW motif-like |
1712 |
0.23 |
chr9_106886021_106887464 | 7.30 |
Rbm15b |
RNA binding motif protein 15B |
686 |
0.53 |
chr12_31185451_31185697 | 7.28 |
6030469F06Rik |
RIKEN cDNA 6030469F06 gene |
951 |
0.48 |
chr11_96929113_96929565 | 7.26 |
Prr15l |
proline rich 15-like |
15 |
0.95 |
chr8_125569269_125570645 | 7.22 |
Sipa1l2 |
signal-induced proliferation-associated 1 like 2 |
149 |
0.97 |
chr18_46719685_46720136 | 7.19 |
Cdo1 |
cysteine dioxygenase 1, cytosolic |
8119 |
0.13 |
chr4_114405732_114406986 | 7.14 |
Trabd2b |
TraB domain containing 2B |
365 |
0.93 |
chr8_87938327_87939174 | 7.12 |
Zfp423 |
zinc finger protein 423 |
5302 |
0.29 |
chr4_95317739_95318363 | 7.05 |
Gm29064 |
predicted gene 29064 |
84739 |
0.08 |
chr14_34588013_34588521 | 7.01 |
Ldb3 |
LIM domain binding 3 |
214 |
0.89 |
chr1_24099625_24100848 | 6.99 |
Fam135a |
family with sequence similarity 135, member A |
20 |
0.87 |
chr5_118981037_118981522 | 6.93 |
Gm43784 |
predicted gene 43784 |
15717 |
0.19 |
chr8_126497512_126498658 | 6.88 |
Gm6091 |
predicted pseudogene 6091 |
21673 |
0.18 |
chr6_99520900_99522395 | 6.82 |
Foxp1 |
forkhead box P1 |
485 |
0.83 |
chr17_28176553_28177770 | 6.82 |
Zfp523 |
zinc finger protein 523 |
2 |
0.89 |
chr6_52165009_52165376 | 6.65 |
Hoxa2 |
homeobox A2 |
361 |
0.46 |
chr7_66929303_66929767 | 6.53 |
Adamts17 |
a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 17 |
20067 |
0.18 |
chr5_122100700_122101295 | 6.50 |
Myl2 |
myosin, light polypeptide 2, regulatory, cardiac, slow |
14 |
0.97 |
chr8_70698268_70700333 | 6.44 |
Jund |
jun D proto-oncogene |
351 |
0.45 |
chr8_84197696_84198961 | 6.39 |
Gm26887 |
predicted gene, 26887 |
661 |
0.38 |
chr2_170070607_170070922 | 6.36 |
Zfp217 |
zinc finger protein 217 |
60456 |
0.14 |
chr12_109417441_109418112 | 6.35 |
Dlk1 |
delta like non-canonical Notch ligand 1 |
35047 |
0.09 |
chr4_128697865_128698491 | 6.30 |
Phc2 |
polyhomeotic 2 |
9383 |
0.19 |
chr13_63564531_63566515 | 6.21 |
Ptch1 |
patched 1 |
212 |
0.91 |
chr15_76200496_76200856 | 6.19 |
Plec |
plectin |
69 |
0.93 |
chr2_27692627_27692976 | 6.18 |
Rxra |
retinoid X receptor alpha |
15539 |
0.24 |
chr7_12012707_12013031 | 6.18 |
Vmn1r-ps60 |
vomeronasal 1 receptor, pseudogene 60 |
7803 |
0.06 |
chr4_150093968_150094140 | 6.13 |
Gpr157 |
G protein-coupled receptor 157 |
6689 |
0.11 |
chr9_107709267_107710507 | 6.07 |
Sema3f |
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3F |
132 |
0.92 |
chr18_3116815_3117174 | 6.02 |
Vmn1r238 |
vomeronasal 1 receptor, 238 |
6418 |
0.16 |
chr14_55824498_55825973 | 5.98 |
Nfatc4 |
nuclear factor of activated T cells, cytoplasmic, calcineurin dependent 4 |
198 |
0.87 |
chr7_46116120_46116518 | 5.89 |
Abcc8 |
ATP-binding cassette, sub-family C (CFTR/MRP), member 8 |
269 |
0.84 |
chr17_78199734_78201570 | 5.88 |
Crim1 |
cysteine rich transmembrane BMP regulator 1 (chordin like) |
267 |
0.74 |
chr7_109196382_109197119 | 5.85 |
Lmo1 |
LIM domain only 1 |
21543 |
0.16 |
chr15_79741326_79742933 | 5.80 |
Sun2 |
Sad1 and UNC84 domain containing 2 |
14 |
0.89 |
chr14_65676139_65676351 | 5.66 |
Scara5 |
scavenger receptor class A, member 5 |
232 |
0.95 |
chr12_3843054_3843635 | 5.64 |
Dnmt3a |
DNA methyltransferase 3A |
6291 |
0.19 |
chr8_120752105_120752314 | 5.63 |
Irf8 |
interferon regulatory factor 8 |
0 |
0.97 |
chr4_142221224_142221954 | 5.63 |
Kazn |
kazrin, periplakin interacting protein |
11383 |
0.22 |
chr17_34898151_34899707 | 5.59 |
Ehmt2 |
euchromatic histone lysine N-methyltransferase 2 |
25 |
0.87 |
chr4_123239382_123240167 | 5.54 |
Heyl |
hairy/enhancer-of-split related with YRPW motif-like |
17 |
0.96 |
chr6_120148701_120149287 | 5.50 |
Gm25327 |
predicted gene, 25327 |
5244 |
0.23 |
chr17_85687855_85689066 | 5.45 |
Six2 |
sine oculis-related homeobox 2 |
186 |
0.94 |
chr1_39900211_39901700 | 5.44 |
Map4k4 |
mitogen-activated protein kinase kinase kinase kinase 4 |
42 |
0.98 |
chr4_131391198_131391382 | 5.38 |
Gm831 |
predicted gene 831 |
95907 |
0.08 |
chr16_37776737_37777678 | 5.35 |
Fstl1 |
follistatin-like 1 |
55 |
0.98 |
chr4_154170746_154171838 | 5.32 |
Megf6 |
multiple EGF-like-domains 6 |
562 |
0.66 |
chr18_58835866_58837093 | 5.30 |
Adamts19 |
a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 19 |
188 |
0.97 |
chr10_91241591_91242005 | 5.29 |
Gm47081 |
predicted gene, 47081 |
13612 |
0.15 |
chr7_19755715_19756107 | 5.28 |
Bcam |
basal cell adhesion molecule |
1040 |
0.27 |
chr14_33707768_33708211 | 5.28 |
Gm26228 |
predicted gene, 26228 |
63494 |
0.1 |
chr3_30507827_30509444 | 5.27 |
Mecom |
MDS1 and EVI1 complex locus |
852 |
0.52 |
chr17_29463763_29464523 | 5.27 |
Gm26885 |
predicted gene, 26885 |
12 |
0.93 |
chr11_78408424_78408863 | 5.26 |
Slc13a2 |
solute carrier family 13 (sodium-dependent dicarboxylate transporter), member 2 |
13574 |
0.09 |
chr5_131722817_131723110 | 5.24 |
Gm42442 |
predicted gene 42442 |
24610 |
0.15 |
chr15_79690079_79691459 | 5.21 |
Gtpbp1 |
GTP binding protein 1 |
76 |
0.92 |
chr8_70609185_70610414 | 5.19 |
Gm45546 |
predicted gene 45546 |
626 |
0.42 |
chr18_36342380_36342857 | 5.18 |
Cystm1 |
cysteine-rich transmembrane module containing 1 |
38 |
0.98 |
chr11_101896932_101897309 | 5.18 |
Meox1 |
mesenchyme homeobox 1 |
2746 |
0.18 |
chr6_112152818_112153218 | 5.17 |
1700054K19Rik |
RIKEN cDNA 1700054K19 gene |
57690 |
0.12 |
chr9_15964185_15964748 | 5.16 |
Fat3 |
FAT atypical cadherin 3 |
6644 |
0.29 |
chr17_46594578_46595070 | 5.15 |
Ptk7 |
PTK7 protein tyrosine kinase 7 |
21874 |
0.09 |
chr2_73774788_73775766 | 5.15 |
Chn1 |
chimerin 1 |
49 |
0.98 |
chr6_92534612_92535000 | 5.15 |
Prickle2 |
prickle planar cell polarity protein 2 |
55 |
0.98 |
chr7_25316512_25317661 | 5.13 |
Megf8 |
multiple EGF-like-domains 8 |
78 |
0.94 |
chr5_115491776_115492524 | 5.11 |
Gm13836 |
predicted gene 13836 |
305 |
0.74 |
chr4_134395625_134396464 | 5.10 |
Pafah2 |
platelet-activating factor acetylhydrolase 2 |
276 |
0.86 |
chr11_68644907_68645071 | 5.10 |
Myh10 |
myosin, heavy polypeptide 10, non-muscle |
46570 |
0.11 |
chr13_99307813_99308164 | 5.09 |
Ptcd2 |
pentatricopeptide repeat domain 2 |
36717 |
0.15 |
chr11_75046892_75047673 | 5.08 |
Gm12333 |
predicted gene 12333 |
7934 |
0.13 |
chr7_28593585_28593828 | 5.08 |
Pak4 |
p21 (RAC1) activated kinase 4 |
4380 |
0.1 |
chr6_84019201_84019427 | 5.04 |
Dysf |
dysferlin |
71 |
0.96 |
chr6_52225788_52226610 | 5.03 |
Hoxa9 |
homeobox A9 |
10 |
0.91 |
chr7_3414948_3415832 | 5.02 |
Gm23450 |
predicted gene, 23450 |
324 |
0.76 |
chr16_45093138_45093744 | 5.01 |
Ccdc80 |
coiled-coil domain containing 80 |
13 |
0.98 |
chr10_60218777_60219527 | 5.00 |
Chst3 |
carbohydrate sulfotransferase 3 |
108 |
0.97 |
chr15_85735270_85736076 | 5.00 |
Ppara |
peroxisome proliferator activated receptor alpha |
34 |
0.97 |
chr10_76642712_76643426 | 4.99 |
Col6a2 |
collagen, type VI, alpha 2 |
19439 |
0.14 |
chr7_116882332_116882634 | 4.98 |
Gm4366 |
predicted gene 4366 |
56632 |
0.13 |
chr2_30601042_30601214 | 4.96 |
Cstad |
CSA-conditional, T cell activation-dependent protein |
4089 |
0.2 |
chr7_136058784_136059216 | 4.94 |
Gm9341 |
predicted gene 9341 |
106202 |
0.06 |
chr13_46417988_46418621 | 4.92 |
Rbm24 |
RNA binding motif protein 24 |
130 |
0.97 |
chr4_141353872_141354190 | 4.92 |
Gm13076 |
predicted gene 13076 |
3060 |
0.12 |
chr18_3118971_3119257 | 4.91 |
Vmn1r238 |
vomeronasal 1 receptor, 238 |
4298 |
0.18 |
chr19_47891876_47892225 | 4.89 |
Gsto2 |
glutathione S-transferase omega 2 |
21788 |
0.12 |
chr11_115899580_115900578 | 4.88 |
Smim5 |
small integral membrane protein 5 |
99 |
0.93 |
chr11_72413067_72413411 | 4.87 |
Smtnl2 |
smoothelin-like 2 |
1526 |
0.28 |
chr10_84533171_84534667 | 4.87 |
Ckap4 |
cytoskeleton-associated protein 4 |
117 |
0.94 |
chr13_55168906_55169382 | 4.87 |
Fgfr4 |
fibroblast growth factor receptor 4 |
13027 |
0.12 |
chr15_80004559_80005217 | 4.85 |
Mir7213 |
microRNA 7213 |
5862 |
0.12 |
chr10_122985267_122986641 | 4.84 |
D630033A02Rik |
RIKEN cDNA D630033A02 gene |
123 |
0.65 |
chr1_12690442_12690837 | 4.84 |
Sulf1 |
sulfatase 1 |
1638 |
0.36 |
chr7_73390556_73391998 | 4.83 |
Rgma |
repulsive guidance molecule family member A |
1 |
0.97 |
chr1_189727337_189728664 | 4.81 |
Ptpn14 |
protein tyrosine phosphatase, non-receptor type 14 |
268 |
0.92 |
chr9_58299371_58299552 | 4.78 |
Loxl1 |
lysyl oxidase-like 1 |
13725 |
0.14 |
chr17_24639409_24639990 | 4.76 |
Nthl1 |
nth (endonuclease III)-like 1 (E.coli) |
1523 |
0.17 |
chr5_115436438_115437458 | 4.76 |
4930430O22Rik |
RIKEN cDNA 4930430O22 gene |
304 |
0.74 |
chr2_174347204_174348264 | 4.76 |
Gm20721 |
predicted gene, 20721 |
1022 |
0.44 |
chr15_34348110_34348431 | 4.75 |
9430069I07Rik |
RIKEN cDNA 9430069I07 gene |
8151 |
0.16 |
chr17_35865439_35866909 | 4.75 |
Ppp1r18 |
protein phosphatase 1, regulatory subunit 18 |
118 |
0.82 |
chr9_67049090_67049794 | 4.75 |
Tpm1 |
tropomyosin 1, alpha |
36 |
0.98 |
chr7_143459115_143459833 | 4.74 |
Cdkn1c |
cyclin-dependent kinase inhibitor 1C (P57) |
163 |
0.64 |
chr4_118229188_118229467 | 4.73 |
Ptprf |
protein tyrosine phosphatase, receptor type, F |
1773 |
0.32 |
chr7_120865040_120865504 | 4.73 |
Gm15774 |
predicted gene 15774 |
10026 |
0.13 |
chr5_134779228_134779595 | 4.72 |
Eln |
elastin |
32088 |
0.12 |
chr1_86527639_86529135 | 4.71 |
Ptma |
prothymosin alpha |
1580 |
0.31 |
chr4_8230038_8230206 | 4.71 |
Gm25355 |
predicted gene, 25355 |
5460 |
0.23 |
chr7_45784749_45786509 | 4.70 |
Lmtk3 |
lemur tyrosine kinase 3 |
119 |
0.87 |
chr6_51334061_51334392 | 4.70 |
Gm6559 |
predicted gene 6559 |
45484 |
0.12 |
chr9_54784115_54784302 | 4.69 |
Crabp1 |
cellular retinoic acid binding protein I |
19460 |
0.14 |
chr2_172872747_172872898 | 4.68 |
Gm22773 |
predicted gene, 22773 |
8481 |
0.24 |
chr12_79574839_79574990 | 4.67 |
Rad51b |
RAD51 paralog B |
247561 |
0.02 |
chr5_135168094_135168944 | 4.65 |
Bcl7b |
B cell CLL/lymphoma 7B |
74 |
0.95 |
chr5_134895107_134895258 | 4.62 |
Tmem270 |
transmembrane protein 270 |
11551 |
0.09 |
chr10_62016778_62017263 | 4.62 |
Gm47919 |
predicted gene, 47919 |
6384 |
0.19 |
chr10_126927752_126928899 | 4.60 |
Atp23 |
ATP23 metallopeptidase and ATP synthase assembly factor homolog |
26970 |
0.09 |
chr11_116694287_116694479 | 4.60 |
St6galnac2 |
ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase 2 |
226 |
0.86 |
chr8_26352467_26353019 | 4.59 |
Gm31784 |
predicted gene, 31784 |
40409 |
0.11 |
chr7_143124014_143124583 | 4.57 |
Gm38321 |
predicted gene, 38321 |
271 |
0.85 |
chr2_174858311_174858924 | 4.55 |
Gm14616 |
predicted gene 14616 |
2328 |
0.26 |
chr5_128599236_128600028 | 4.51 |
Fzd10os |
frizzled class receptor 10, opposite strand |
1022 |
0.34 |
chrX_123943434_123943951 | 4.48 |
Rps12-ps20 |
ribosomal protein S12, pseudogene 20 |
13582 |
0.23 |
chr2_125505483_125506537 | 4.48 |
Fbn1 |
fibrillin 1 |
62 |
0.95 |
chr9_63896391_63896836 | 4.47 |
Gm18541 |
predicted gene, 18541 |
1652 |
0.39 |
chr7_34714918_34715250 | 4.46 |
Chst8 |
carbohydrate sulfotransferase 8 |
17634 |
0.16 |
chr7_142516289_142516803 | 4.44 |
Tnnt3 |
troponin T3, skeletal, fast |
2416 |
0.16 |
chr7_19094759_19096427 | 4.43 |
Six5 |
sine oculis-related homeobox 5 |
999 |
0.28 |
chr2_121289033_121290183 | 4.43 |
Map1a |
microtubule-associated protein 1 A |
8 |
0.96 |
chr4_136104800_136105070 | 4.42 |
Gm13009 |
predicted gene 13009 |
29963 |
0.1 |
chr11_88555646_88556084 | 4.42 |
Msi2 |
musashi RNA-binding protein 2 |
34282 |
0.19 |
chr7_46013301_46013656 | 4.41 |
Abcc6 |
ATP-binding cassette, sub-family C (CFTR/MRP), member 6 |
12409 |
0.11 |
chrX_123721926_123722462 | 4.40 |
Rps12-ps23 |
ribosomal protein S12, pseudogene 23 |
13617 |
0.18 |
chr8_25074684_25075074 | 4.40 |
Plekha2 |
pleckstrin homology domain-containing, family A (phosphoinositide binding specific) member 2 |
16467 |
0.12 |
chrX_123500550_123501093 | 4.39 |
Rps12-ps22 |
ribosomal protein S12, pseudogene 22 |
13606 |
0.18 |
chr3_105714128_105714582 | 4.38 |
Inka2 |
inka box actin regulator 2 |
8897 |
0.11 |
chr2_66124084_66125291 | 4.38 |
Galnt3 |
polypeptide N-acetylgalactosaminyltransferase 3 |
307 |
0.72 |
chr7_5060805_5061447 | 4.36 |
Gm45133 |
predicted gene 45133 |
923 |
0.22 |
chr11_96075098_96076163 | 4.36 |
Atp5g1 |
ATP synthase, H+ transporting, mitochondrial F0 complex, subunit C1 (subunit 9) |
11 |
0.95 |
chrX_123271195_123271712 | 4.36 |
Rps12-ps21 |
ribosomal protein S12, pseudogene 22 |
13591 |
0.15 |
chr4_62732780_62733235 | 4.35 |
Gm11211 |
predicted gene 11211 |
5470 |
0.19 |
chr19_53670851_53671086 | 4.35 |
Rbm20 |
RNA binding motif protein 20 |
6338 |
0.19 |
chr4_141598441_141598939 | 4.35 |
Fblim1 |
filamin binding LIM protein 1 |
173 |
0.91 |
chr9_42109837_42110045 | 4.33 |
Sorl1 |
sortilin-related receptor, LDLR class A repeats-containing |
14356 |
0.2 |
chr13_60409685_60410003 | 4.33 |
Gm35333 |
predicted gene, 35333 |
17354 |
0.19 |
chr11_68601519_68601724 | 4.33 |
Ccdc42 |
coiled-coil domain containing 42 |
7566 |
0.17 |
chr2_153436314_153437355 | 4.32 |
Nol4l |
nucleolar protein 4-like |
7645 |
0.17 |
chr4_141420963_141421789 | 4.31 |
Hspb7 |
heat shock protein family, member 7 (cardiovascular) |
597 |
0.56 |
chr5_113789227_113789902 | 4.31 |
Tmem119 |
transmembrane protein 119 |
10882 |
0.09 |
chr1_135199042_135199812 | 4.30 |
Gpr37l1 |
G protein-coupled receptor 37-like 1 |
31746 |
0.08 |
chr18_61054859_61055047 | 4.28 |
Pdgfrb |
platelet derived growth factor receptor, beta polypeptide |
9753 |
0.13 |
chr8_104602539_104603204 | 4.28 |
Cdh16 |
cadherin 16 |
10393 |
0.09 |
chr18_5809435_5809625 | 4.28 |
Zeb1 |
zinc finger E-box binding homeobox 1 |
78449 |
0.1 |
chr16_9092221_9092372 | 4.27 |
Gm49448 |
predicted gene, 49448 |
12151 |
0.18 |
chr11_98922365_98923607 | 4.26 |
Cdc6 |
cell division cycle 6 |
2520 |
0.16 |
chr6_29434698_29434849 | 4.26 |
Flnc |
filamin C, gamma |
1497 |
0.24 |
chr8_36528292_36528784 | 4.26 |
Trmt9b |
tRNA methyltransferase 9B |
23049 |
0.2 |
chr5_122510586_122510930 | 4.26 |
Gm22965 |
predicted gene, 22965 |
3969 |
0.12 |
chr17_47923769_47925323 | 4.26 |
Foxp4 |
forkhead box P4 |
70 |
0.96 |
chr11_101881665_101882072 | 4.24 |
Gm11551 |
predicted gene 11551 |
4369 |
0.15 |
chr1_135800050_135801209 | 4.23 |
Tnni1 |
troponin I, skeletal, slow 1 |
796 |
0.55 |
chr7_142497921_142498072 | 4.22 |
Tnnt3 |
troponin T3, skeletal, fast |
840 |
0.35 |
chr1_89120214_89120551 | 4.21 |
Gm38312 |
predicted gene, 38312 |
23309 |
0.19 |
chr10_60814402_60815129 | 4.20 |
Gm19972 |
predicted gene, 19972 |
442 |
0.82 |
chr2_119236988_119237799 | 4.20 |
Spint1 |
serine protease inhibitor, Kunitz type 1 |
31 |
0.95 |
chr8_116252557_116252721 | 4.20 |
4930422C21Rik |
RIKEN cDNA 4930422C21 gene |
65270 |
0.13 |
chr8_11357901_11358379 | 4.20 |
Col4a1 |
collagen, type IV, alpha 1 |
45314 |
0.1 |
chr5_131307236_131308204 | 4.19 |
Galnt17 |
polypeptide N-acetylgalactosaminyltransferase 17 |
153 |
0.97 |
chr7_143389159_143390008 | 4.17 |
4933417O13Rik |
RIKEN cDNA 4933417O13 gene |
24958 |
0.12 |
chr1_85100419_85100892 | 4.17 |
Gm10553 |
predicted gene 10553 |
491 |
0.64 |
chr17_85748614_85749073 | 4.17 |
CJ186046Rik |
Riken cDNA CJ186046 gene |
55214 |
0.11 |
chr7_110982017_110982316 | 4.15 |
Mrvi1 |
MRV integration site 1 |
38 |
0.98 |
chr12_79929128_79929324 | 4.14 |
9430078K24Rik |
RIKEN cDNA 9430078K24 gene |
3732 |
0.24 |
chr7_45313102_45313253 | 4.12 |
Trpm4 |
transient receptor potential cation channel, subfamily M, member 4 |
1609 |
0.16 |
chr13_94069447_94069782 | 4.12 |
Lhfpl2 |
lipoma HMGIC fusion partner-like 2 |
11782 |
0.18 |
chr13_98590809_98590960 | 4.11 |
Gm4815 |
predicted gene 4815 |
22617 |
0.11 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.8 | 11.7 | GO:2000591 | positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:0035793) regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:1900238) positive regulation of metanephric mesenchymal cell migration(GO:2000591) |
5.2 | 20.8 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
4.8 | 14.5 | GO:0097623 | potassium ion export across plasma membrane(GO:0097623) |
4.8 | 14.4 | GO:0036166 | phenotypic switching(GO:0036166) |
4.2 | 20.8 | GO:0055009 | atrial cardiac muscle tissue development(GO:0003228) atrial cardiac muscle tissue morphogenesis(GO:0055009) |
4.0 | 11.9 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
3.9 | 15.7 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
3.6 | 18.2 | GO:1902894 | negative regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902894) |
3.6 | 3.6 | GO:0010159 | specification of organ position(GO:0010159) |
3.5 | 10.6 | GO:0003431 | growth plate cartilage chondrocyte development(GO:0003431) |
3.5 | 10.5 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
3.4 | 10.2 | GO:2000823 | regulation of androgen receptor activity(GO:2000823) |
3.4 | 10.2 | GO:0042706 | eye photoreceptor cell fate commitment(GO:0042706) photoreceptor cell fate commitment(GO:0046552) |
3.4 | 10.1 | GO:0060594 | mammary gland specification(GO:0060594) |
3.3 | 13.4 | GO:0003176 | aortic valve development(GO:0003176) aortic valve morphogenesis(GO:0003180) |
3.3 | 9.9 | GO:0097168 | mesenchymal stem cell proliferation(GO:0097168) |
3.3 | 6.5 | GO:0060686 | negative regulation of prostatic bud formation(GO:0060686) |
3.2 | 16.2 | GO:0021563 | glossopharyngeal nerve development(GO:0021563) |
3.2 | 25.9 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
3.1 | 6.3 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
3.1 | 15.4 | GO:1902459 | positive regulation of stem cell population maintenance(GO:1902459) |
2.9 | 11.7 | GO:0052200 | response to defenses of other organism involved in symbiotic interaction(GO:0052173) response to host defenses(GO:0052200) response to host(GO:0075136) |
2.9 | 11.7 | GO:0071692 | protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
2.9 | 17.2 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
2.8 | 8.5 | GO:0072095 | regulation of branch elongation involved in ureteric bud branching(GO:0072095) |
2.8 | 11.4 | GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) |
2.8 | 8.5 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
2.8 | 8.5 | GO:0003062 | regulation of heart rate by chemical signal(GO:0003062) |
2.8 | 5.6 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
2.8 | 2.8 | GO:2000977 | regulation of forebrain neuron differentiation(GO:2000977) |
2.8 | 16.6 | GO:0060481 | lobar bronchus epithelium development(GO:0060481) |
2.7 | 8.1 | GO:0048769 | sarcomerogenesis(GO:0048769) |
2.7 | 10.8 | GO:0061205 | paramesonephric duct development(GO:0061205) |
2.7 | 8.1 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
2.7 | 8.1 | GO:0048371 | lateral mesoderm morphogenesis(GO:0048369) lateral mesoderm formation(GO:0048370) lateral mesodermal cell differentiation(GO:0048371) |
2.7 | 8.1 | GO:0021775 | smoothened signaling pathway involved in ventral spinal cord interneuron specification(GO:0021775) smoothened signaling pathway involved in spinal cord motor neuron cell fate specification(GO:0021776) |
2.7 | 8.0 | GO:1902564 | negative regulation of neutrophil activation(GO:1902564) |
2.7 | 10.7 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
2.6 | 7.9 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
2.5 | 19.8 | GO:0014883 | transition between fast and slow fiber(GO:0014883) |
2.5 | 2.5 | GO:0021943 | formation of radial glial scaffolds(GO:0021943) |
2.5 | 19.7 | GO:0001778 | plasma membrane repair(GO:0001778) |
2.4 | 4.9 | GO:0003166 | bundle of His development(GO:0003166) |
2.4 | 9.7 | GO:0035290 | trunk segmentation(GO:0035290) trunk neural crest cell migration(GO:0036484) ventral trunk neural crest cell migration(GO:0036486) sympathetic neuron projection extension(GO:0097490) sympathetic neuron projection guidance(GO:0097491) |
2.4 | 7.2 | GO:0046103 | inosine biosynthetic process(GO:0046103) |
2.4 | 2.4 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
2.3 | 7.0 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
2.3 | 7.0 | GO:0010482 | epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
2.3 | 7.0 | GO:0061626 | pharyngeal arch artery morphogenesis(GO:0061626) |
2.3 | 9.3 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
2.3 | 2.3 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
2.3 | 2.3 | GO:0048319 | axial mesoderm morphogenesis(GO:0048319) |
2.3 | 11.4 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
2.2 | 4.4 | GO:0072275 | glomerulus vasculature morphogenesis(GO:0072103) glomerular capillary formation(GO:0072104) metanephric glomerulus morphogenesis(GO:0072275) metanephric glomerulus vasculature morphogenesis(GO:0072276) metanephric glomerular capillary formation(GO:0072277) |
2.2 | 4.4 | GO:0044333 | Wnt signaling pathway involved in digestive tract morphogenesis(GO:0044333) |
2.2 | 6.5 | GO:1903849 | regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
2.1 | 4.3 | GO:0060448 | dichotomous subdivision of terminal units involved in lung branching(GO:0060448) |
2.1 | 2.1 | GO:1902730 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
2.1 | 12.6 | GO:0045630 | positive regulation of T-helper 2 cell differentiation(GO:0045630) |
2.1 | 6.3 | GO:0003256 | regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation(GO:0003256) |
2.1 | 10.4 | GO:0060836 | lymphatic endothelial cell differentiation(GO:0060836) |
2.0 | 2.0 | GO:0060681 | branch elongation involved in ureteric bud branching(GO:0060681) |
2.0 | 6.0 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
2.0 | 5.9 | GO:0032079 | positive regulation of endodeoxyribonuclease activity(GO:0032079) |
1.9 | 3.9 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
1.9 | 5.8 | GO:0021938 | smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation(GO:0021938) |
1.9 | 1.9 | GO:0090027 | negative regulation of monocyte chemotaxis(GO:0090027) |
1.9 | 5.7 | GO:0000101 | sulfur amino acid transport(GO:0000101) |
1.9 | 7.5 | GO:0021569 | rhombomere 3 development(GO:0021569) |
1.9 | 7.5 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
1.9 | 1.9 | GO:0038109 | response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
1.9 | 5.6 | GO:0060671 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
1.8 | 1.8 | GO:0035993 | deltoid tuberosity development(GO:0035993) |
1.8 | 5.5 | GO:0007525 | somatic muscle development(GO:0007525) |
1.8 | 5.4 | GO:0097503 | sialylation(GO:0097503) |
1.8 | 5.4 | GO:0003347 | epicardial cell to mesenchymal cell transition(GO:0003347) |
1.8 | 3.6 | GO:0014826 | vein smooth muscle contraction(GO:0014826) |
1.8 | 3.6 | GO:0072191 | ureter smooth muscle development(GO:0072191) ureter smooth muscle cell differentiation(GO:0072193) |
1.8 | 10.8 | GO:0051639 | actin filament network formation(GO:0051639) |
1.8 | 1.8 | GO:0021564 | vagus nerve development(GO:0021564) |
1.8 | 7.0 | GO:0071680 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
1.8 | 1.8 | GO:0021570 | rhombomere 4 development(GO:0021570) |
1.8 | 1.8 | GO:0071698 | olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
1.7 | 1.7 | GO:0042524 | negative regulation of tyrosine phosphorylation of Stat5 protein(GO:0042524) |
1.7 | 1.7 | GO:0048865 | stem cell fate commitment(GO:0048865) |
1.7 | 3.4 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
1.7 | 5.1 | GO:2001055 | positive regulation of mesenchymal cell apoptotic process(GO:2001055) |
1.7 | 1.7 | GO:0007403 | glial cell fate determination(GO:0007403) |
1.7 | 5.1 | GO:0051890 | regulation of cardioblast differentiation(GO:0051890) |
1.7 | 5.1 | GO:0032474 | otolith morphogenesis(GO:0032474) |
1.7 | 5.0 | GO:1903116 | positive regulation of actin filament-based movement(GO:1903116) |
1.7 | 8.4 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
1.7 | 3.3 | GO:0060347 | heart trabecula formation(GO:0060347) |
1.6 | 4.9 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
1.6 | 3.2 | GO:0018992 | germ-line sex determination(GO:0018992) |
1.6 | 6.4 | GO:1903142 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
1.6 | 11.0 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
1.6 | 15.7 | GO:0032060 | bleb assembly(GO:0032060) |
1.6 | 3.1 | GO:0035799 | ureter maturation(GO:0035799) |
1.6 | 10.9 | GO:0099515 | actin filament-based transport(GO:0099515) |
1.5 | 1.5 | GO:1900222 | negative regulation of beta-amyloid clearance(GO:1900222) |
1.5 | 9.2 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
1.5 | 1.5 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
1.5 | 1.5 | GO:0060482 | lobar bronchus development(GO:0060482) |
1.5 | 7.6 | GO:0016576 | histone dephosphorylation(GO:0016576) |
1.5 | 7.6 | GO:2000618 | regulation of histone H4-K16 acetylation(GO:2000618) |
1.5 | 3.0 | GO:1902988 | neurofibrillary tangle assembly(GO:1902988) regulation of neurofibrillary tangle assembly(GO:1902996) |
1.5 | 4.5 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
1.5 | 5.9 | GO:0034454 | microtubule anchoring at centrosome(GO:0034454) |
1.5 | 1.5 | GO:0060033 | anatomical structure regression(GO:0060033) |
1.5 | 7.4 | GO:0072675 | osteoclast fusion(GO:0072675) |
1.5 | 4.4 | GO:0042091 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
1.5 | 8.8 | GO:0042118 | endothelial cell activation(GO:0042118) |
1.5 | 7.3 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
1.5 | 2.9 | GO:1900825 | regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900825) |
1.5 | 7.3 | GO:1903799 | negative regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903799) |
1.4 | 2.9 | GO:0007494 | midgut development(GO:0007494) |
1.4 | 2.9 | GO:2001197 | regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904259) positive regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904261) basement membrane assembly involved in embryonic body morphogenesis(GO:2001197) |
1.4 | 8.7 | GO:0050748 | negative regulation of lipoprotein metabolic process(GO:0050748) |
1.4 | 1.4 | GO:2000343 | positive regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000343) |
1.4 | 5.7 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
1.4 | 7.1 | GO:1903689 | regulation of wound healing, spreading of epidermal cells(GO:1903689) |
1.4 | 4.2 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
1.4 | 1.4 | GO:0060584 | regulation of prostaglandin-endoperoxide synthase activity(GO:0060584) positive regulation of prostaglandin-endoperoxide synthase activity(GO:0060585) |
1.4 | 2.8 | GO:0003177 | pulmonary valve development(GO:0003177) pulmonary valve morphogenesis(GO:0003184) |
1.4 | 2.8 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
1.4 | 5.5 | GO:0034447 | very-low-density lipoprotein particle clearance(GO:0034447) |
1.4 | 13.6 | GO:0046322 | negative regulation of fatty acid oxidation(GO:0046322) |
1.4 | 4.1 | GO:1904180 | negative regulation of mitochondrial depolarization(GO:0051902) negative regulation of membrane depolarization(GO:1904180) |
1.4 | 10.9 | GO:1904321 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
1.3 | 2.7 | GO:0060931 | sinoatrial node cell differentiation(GO:0060921) sinoatrial node cell development(GO:0060931) |
1.3 | 9.4 | GO:0070874 | negative regulation of glycogen metabolic process(GO:0070874) |
1.3 | 2.7 | GO:0035054 | embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
1.3 | 6.7 | GO:0060484 | lung-associated mesenchyme development(GO:0060484) |
1.3 | 2.7 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
1.3 | 4.0 | GO:0070314 | G1 to G0 transition(GO:0070314) |
1.3 | 2.6 | GO:1902075 | cellular response to salt(GO:1902075) |
1.3 | 1.3 | GO:0071415 | cellular response to caffeine(GO:0071313) cellular response to purine-containing compound(GO:0071415) |
1.3 | 1.3 | GO:0048715 | negative regulation of oligodendrocyte differentiation(GO:0048715) |
1.3 | 1.3 | GO:1900104 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
1.3 | 32.2 | GO:0045214 | sarcomere organization(GO:0045214) |
1.3 | 3.9 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
1.3 | 7.7 | GO:0038089 | positive regulation of cell migration by vascular endothelial growth factor signaling pathway(GO:0038089) |
1.3 | 1.3 | GO:0036120 | response to platelet-derived growth factor(GO:0036119) cellular response to platelet-derived growth factor stimulus(GO:0036120) |
1.3 | 1.3 | GO:0021555 | midbrain-hindbrain boundary morphogenesis(GO:0021555) |
1.3 | 1.3 | GO:0072092 | ureteric bud invasion(GO:0072092) metanephric renal vesicle formation(GO:0072093) |
1.3 | 6.3 | GO:0035878 | nail development(GO:0035878) |
1.3 | 3.8 | GO:1904238 | pericyte cell differentiation(GO:1904238) |
1.3 | 26.5 | GO:0030513 | positive regulation of BMP signaling pathway(GO:0030513) |
1.3 | 1.3 | GO:0060423 | foregut regionalization(GO:0060423) lung field specification(GO:0060424) lung induction(GO:0060492) |
1.3 | 2.5 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
1.3 | 1.3 | GO:1904948 | midbrain dopaminergic neuron differentiation(GO:1904948) |
1.2 | 5.0 | GO:1901628 | positive regulation of postsynaptic membrane organization(GO:1901628) regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904393) positive regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904395) |
1.2 | 1.2 | GO:0003253 | cardiac neural crest cell migration involved in outflow tract morphogenesis(GO:0003253) |
1.2 | 6.2 | GO:0038030 | non-canonical Wnt signaling pathway via MAPK cascade(GO:0038030) |
1.2 | 1.2 | GO:0072176 | nephric duct development(GO:0072176) nephric duct morphogenesis(GO:0072178) |
1.2 | 13.6 | GO:0002076 | osteoblast development(GO:0002076) |
1.2 | 11.1 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
1.2 | 4.9 | GO:1900194 | negative regulation of oocyte maturation(GO:1900194) |
1.2 | 1.2 | GO:0061031 | endodermal digestive tract morphogenesis(GO:0061031) |
1.2 | 4.9 | GO:0010991 | negative regulation of SMAD protein complex assembly(GO:0010991) |
1.2 | 1.2 | GO:0007199 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger(GO:0007199) |
1.2 | 3.6 | GO:0001880 | Mullerian duct regression(GO:0001880) |
1.2 | 1.2 | GO:0032513 | regulation of protein phosphatase type 2B activity(GO:0032512) negative regulation of protein phosphatase type 2B activity(GO:0032513) |
1.2 | 2.4 | GO:0045091 | regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045091) |
1.2 | 2.4 | GO:0051794 | regulation of catagen(GO:0051794) |
1.2 | 3.6 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
1.2 | 4.7 | GO:0060718 | chorionic trophoblast cell differentiation(GO:0060718) |
1.2 | 8.2 | GO:0045634 | regulation of melanocyte differentiation(GO:0045634) |
1.2 | 2.3 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
1.2 | 9.4 | GO:0045618 | positive regulation of keratinocyte differentiation(GO:0045618) |
1.2 | 7.0 | GO:0018158 | protein oxidation(GO:0018158) |
1.2 | 2.3 | GO:0071608 | macrophage inflammatory protein-1 alpha production(GO:0071608) |
1.2 | 5.8 | GO:1904424 | regulation of GTP binding(GO:1904424) |
1.2 | 3.5 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
1.2 | 1.2 | GO:0072050 | S-shaped body morphogenesis(GO:0072050) |
1.1 | 2.3 | GO:0036022 | limb joint morphogenesis(GO:0036022) embryonic skeletal limb joint morphogenesis(GO:0036023) |
1.1 | 3.4 | GO:0086043 | bundle of His cell to Purkinje myocyte signaling(GO:0086028) bundle of His cell action potential(GO:0086043) |
1.1 | 3.4 | GO:0071895 | odontoblast differentiation(GO:0071895) |
1.1 | 6.8 | GO:0051764 | actin crosslink formation(GO:0051764) |
1.1 | 3.4 | GO:0061525 | hindgut development(GO:0061525) |
1.1 | 3.4 | GO:0010748 | negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) |
1.1 | 2.2 | GO:2001046 | positive regulation of integrin-mediated signaling pathway(GO:2001046) |
1.1 | 3.3 | GO:0010424 | DNA methylation on cytosine within a CG sequence(GO:0010424) DNA methylation on cytosine(GO:0032776) |
1.1 | 1.1 | GO:0055118 | negative regulation of cardiac muscle contraction(GO:0055118) |
1.1 | 7.8 | GO:0048251 | elastic fiber assembly(GO:0048251) |
1.1 | 3.3 | GO:1903423 | positive regulation of synaptic vesicle recycling(GO:1903423) |
1.1 | 1.1 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
1.1 | 6.6 | GO:0051775 | response to redox state(GO:0051775) |
1.1 | 3.3 | GO:2001268 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
1.1 | 2.2 | GO:0042662 | negative regulation of mesodermal cell fate specification(GO:0042662) |
1.1 | 2.2 | GO:0061002 | negative regulation of dendritic spine morphogenesis(GO:0061002) |
1.1 | 10.8 | GO:0001553 | luteinization(GO:0001553) |
1.1 | 2.2 | GO:0016264 | gap junction assembly(GO:0016264) |
1.1 | 3.2 | GO:0060336 | negative regulation of response to interferon-gamma(GO:0060331) negative regulation of interferon-gamma-mediated signaling pathway(GO:0060336) |
1.1 | 1.1 | GO:0072053 | renal inner medulla development(GO:0072053) |
1.1 | 4.3 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
1.1 | 4.3 | GO:0071225 | cellular response to muramyl dipeptide(GO:0071225) |
1.1 | 8.5 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
1.1 | 4.3 | GO:0098728 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
1.1 | 3.2 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
1.1 | 3.2 | GO:0048295 | positive regulation of isotype switching to IgE isotypes(GO:0048295) |
1.1 | 5.3 | GO:0010626 | negative regulation of Schwann cell proliferation(GO:0010626) |
1.0 | 3.1 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
1.0 | 2.1 | GO:0021558 | trochlear nerve development(GO:0021558) |
1.0 | 3.1 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
1.0 | 1.0 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
1.0 | 3.1 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
1.0 | 4.1 | GO:0072257 | metanephric nephron tubule epithelial cell differentiation(GO:0072257) regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072307) |
1.0 | 1.0 | GO:2000391 | regulation of neutrophil extravasation(GO:2000389) positive regulation of neutrophil extravasation(GO:2000391) |
1.0 | 3.1 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
1.0 | 3.1 | GO:0098903 | regulation of membrane repolarization during action potential(GO:0098903) |
1.0 | 6.1 | GO:0060087 | relaxation of vascular smooth muscle(GO:0060087) |
1.0 | 12.1 | GO:0022038 | corpus callosum development(GO:0022038) |
1.0 | 1.0 | GO:1901509 | regulation of endothelial tube morphogenesis(GO:1901509) |
1.0 | 4.0 | GO:1903797 | positive regulation of inorganic anion transmembrane transport(GO:1903797) |
1.0 | 7.9 | GO:0060272 | embryonic skeletal joint morphogenesis(GO:0060272) |
1.0 | 2.0 | GO:0030240 | skeletal muscle thin filament assembly(GO:0030240) |
1.0 | 3.9 | GO:0071847 | TNFSF11-mediated signaling pathway(GO:0071847) |
1.0 | 2.9 | GO:0060510 | Type II pneumocyte differentiation(GO:0060510) |
1.0 | 4.9 | GO:0034651 | cortisol biosynthetic process(GO:0034651) |
1.0 | 4.8 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
1.0 | 1.0 | GO:0035984 | response to trichostatin A(GO:0035983) cellular response to trichostatin A(GO:0035984) |
1.0 | 1.9 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
1.0 | 2.9 | GO:0035482 | gastric motility(GO:0035482) |
1.0 | 1.0 | GO:1905005 | regulation of epithelial to mesenchymal transition involved in endocardial cushion formation(GO:1905005) |
1.0 | 1.9 | GO:1901420 | negative regulation of response to alcohol(GO:1901420) |
1.0 | 1.9 | GO:0034137 | positive regulation of toll-like receptor 2 signaling pathway(GO:0034137) |
0.9 | 2.8 | GO:0072173 | metanephric tubule morphogenesis(GO:0072173) |
0.9 | 12.2 | GO:0001945 | lymph vessel development(GO:0001945) |
0.9 | 4.7 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
0.9 | 4.7 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
0.9 | 3.8 | GO:0045602 | negative regulation of endothelial cell differentiation(GO:0045602) |
0.9 | 0.9 | GO:0060426 | lung vasculature development(GO:0060426) |
0.9 | 0.9 | GO:0060684 | epithelial-mesenchymal cell signaling(GO:0060684) |
0.9 | 2.8 | GO:0001915 | negative regulation of T cell mediated cytotoxicity(GO:0001915) |
0.9 | 2.8 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
0.9 | 2.7 | GO:1905216 | positive regulation of mRNA binding(GO:1902416) positive regulation of RNA binding(GO:1905216) |
0.9 | 3.7 | GO:1904995 | negative regulation of leukocyte adhesion to vascular endothelial cell(GO:1904995) |
0.9 | 10.0 | GO:0051497 | negative regulation of stress fiber assembly(GO:0051497) |
0.9 | 0.9 | GO:0035284 | rhombomere 5 development(GO:0021571) central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
0.9 | 2.7 | GO:0048170 | positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
0.9 | 0.9 | GO:0098902 | regulation of membrane depolarization during action potential(GO:0098902) |
0.9 | 1.8 | GO:0097113 | AMPA glutamate receptor clustering(GO:0097113) glutamate receptor clustering(GO:0097688) |
0.9 | 1.8 | GO:0033088 | negative regulation of immature T cell proliferation in thymus(GO:0033088) |
0.9 | 0.9 | GO:0042663 | regulation of endodermal cell fate specification(GO:0042663) |
0.9 | 1.8 | GO:2000828 | regulation of parathyroid hormone secretion(GO:2000828) |
0.9 | 4.5 | GO:0043586 | tongue development(GO:0043586) |
0.9 | 3.6 | GO:0048539 | bone marrow development(GO:0048539) |
0.9 | 3.6 | GO:0003148 | outflow tract septum morphogenesis(GO:0003148) |
0.9 | 0.9 | GO:0061144 | alveolar secondary septum development(GO:0061144) |
0.9 | 3.5 | GO:0060391 | positive regulation of SMAD protein import into nucleus(GO:0060391) |
0.9 | 17.5 | GO:0030865 | cortical cytoskeleton organization(GO:0030865) |
0.9 | 8.7 | GO:0033623 | regulation of integrin activation(GO:0033623) |
0.9 | 1.7 | GO:0008050 | female courtship behavior(GO:0008050) |
0.9 | 5.2 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.9 | 8.7 | GO:0048484 | enteric nervous system development(GO:0048484) |
0.9 | 1.7 | GO:0090154 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
0.9 | 2.6 | GO:2000860 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
0.9 | 2.6 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.9 | 2.6 | GO:0038044 | transforming growth factor-beta secretion(GO:0038044) regulation of transforming growth factor-beta secretion(GO:2001201) |
0.9 | 2.6 | GO:0051365 | cellular response to potassium ion starvation(GO:0051365) |
0.9 | 3.4 | GO:0060068 | vagina development(GO:0060068) |
0.9 | 3.4 | GO:1904683 | regulation of metalloendopeptidase activity(GO:1904683) |
0.9 | 4.3 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
0.9 | 1.7 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
0.9 | 5.1 | GO:0033630 | positive regulation of cell adhesion mediated by integrin(GO:0033630) |
0.8 | 3.4 | GO:0007296 | vitellogenesis(GO:0007296) |
0.8 | 6.8 | GO:1900121 | negative regulation of receptor binding(GO:1900121) |
0.8 | 2.5 | GO:0030035 | microspike assembly(GO:0030035) |
0.8 | 2.5 | GO:0070100 | negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
0.8 | 3.4 | GO:0046643 | regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
0.8 | 2.5 | GO:0060160 | negative regulation of dopamine receptor signaling pathway(GO:0060160) |
0.8 | 3.3 | GO:1902414 | protein localization to cell junction(GO:1902414) |
0.8 | 4.9 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
0.8 | 1.6 | GO:0010887 | negative regulation of cholesterol storage(GO:0010887) |
0.8 | 2.5 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.8 | 4.9 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.8 | 2.5 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
0.8 | 3.3 | GO:0034755 | iron ion transmembrane transport(GO:0034755) |
0.8 | 2.4 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
0.8 | 3.2 | GO:0048368 | lateral mesoderm development(GO:0048368) |
0.8 | 6.5 | GO:0070571 | negative regulation of neuron projection regeneration(GO:0070571) |
0.8 | 1.6 | GO:1902430 | negative regulation of beta-amyloid formation(GO:1902430) |
0.8 | 33.9 | GO:0007044 | cell-substrate junction assembly(GO:0007044) |
0.8 | 0.8 | GO:0038145 | macrophage colony-stimulating factor signaling pathway(GO:0038145) |
0.8 | 1.6 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
0.8 | 2.4 | GO:0042518 | negative regulation of tyrosine phosphorylation of Stat3 protein(GO:0042518) |
0.8 | 6.4 | GO:0043922 | negative regulation by host of viral transcription(GO:0043922) |
0.8 | 0.8 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
0.8 | 2.4 | GO:0014894 | response to inactivity(GO:0014854) response to muscle inactivity(GO:0014870) response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
0.8 | 5.6 | GO:0060065 | uterus development(GO:0060065) |
0.8 | 0.8 | GO:0003104 | positive regulation of glomerular filtration(GO:0003104) |
0.8 | 2.4 | GO:0051572 | negative regulation of histone H3-K4 methylation(GO:0051572) |
0.8 | 0.8 | GO:0048625 | myoblast fate commitment(GO:0048625) |
0.8 | 1.6 | GO:0048682 | axon extension involved in regeneration(GO:0048677) sprouting of injured axon(GO:0048682) |
0.8 | 1.6 | GO:0048842 | positive regulation of axon extension involved in axon guidance(GO:0048842) positive regulation of axon guidance(GO:1902669) |
0.8 | 2.3 | GO:0010715 | regulation of extracellular matrix disassembly(GO:0010715) |
0.8 | 3.1 | GO:0060029 | convergent extension involved in organogenesis(GO:0060029) |
0.8 | 3.9 | GO:0071404 | cellular response to low-density lipoprotein particle stimulus(GO:0071404) |
0.8 | 0.8 | GO:0003338 | metanephros morphogenesis(GO:0003338) |
0.8 | 2.3 | GO:0010248 | establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
0.8 | 5.4 | GO:2000653 | regulation of genetic imprinting(GO:2000653) |
0.8 | 1.6 | GO:1904177 | regulation of adipose tissue development(GO:1904177) |
0.8 | 2.3 | GO:0007039 | protein catabolic process in the vacuole(GO:0007039) |
0.8 | 2.3 | GO:0010288 | response to lead ion(GO:0010288) |
0.8 | 1.5 | GO:0090179 | planar cell polarity pathway involved in neural tube closure(GO:0090179) |
0.8 | 1.5 | GO:0061625 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) glycolytic process through fructose-1-phosphate(GO:0061625) |
0.8 | 2.3 | GO:0042222 | interleukin-1 biosynthetic process(GO:0042222) |
0.8 | 6.1 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.8 | 1.5 | GO:0050955 | thermoception(GO:0050955) |
0.8 | 0.8 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.8 | 3.0 | GO:0007183 | SMAD protein complex assembly(GO:0007183) |
0.8 | 2.3 | GO:0060766 | negative regulation of androgen receptor signaling pathway(GO:0060766) |
0.8 | 5.3 | GO:0070886 | positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
0.8 | 0.8 | GO:0060157 | urinary bladder development(GO:0060157) |
0.8 | 2.3 | GO:0002121 | inter-male aggressive behavior(GO:0002121) |
0.7 | 2.2 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
0.7 | 0.7 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
0.7 | 5.2 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
0.7 | 1.5 | GO:0097242 | beta-amyloid clearance(GO:0097242) |
0.7 | 3.7 | GO:0014912 | negative regulation of smooth muscle cell migration(GO:0014912) |
0.7 | 2.9 | GO:0006742 | NADP catabolic process(GO:0006742) |
0.7 | 6.6 | GO:0042475 | odontogenesis of dentin-containing tooth(GO:0042475) |
0.7 | 0.7 | GO:0002351 | serotonin production involved in inflammatory response(GO:0002351) serotonin secretion involved in inflammatory response(GO:0002442) serotonin secretion by platelet(GO:0002554) |
0.7 | 8.0 | GO:0060445 | branching involved in salivary gland morphogenesis(GO:0060445) |
0.7 | 2.2 | GO:2001181 | positive regulation of interleukin-10 secretion(GO:2001181) |
0.7 | 5.1 | GO:0001866 | NK T cell proliferation(GO:0001866) |
0.7 | 2.9 | GO:0072553 | terminal button organization(GO:0072553) |
0.7 | 2.2 | GO:0035633 | maintenance of blood-brain barrier(GO:0035633) |
0.7 | 2.2 | GO:0098700 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) neurotransmitter loading into synaptic vesicle(GO:0098700) |
0.7 | 2.2 | GO:0034287 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
0.7 | 0.7 | GO:0060748 | tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) |
0.7 | 2.2 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) |
0.7 | 0.7 | GO:0033278 | cell proliferation in midbrain(GO:0033278) |
0.7 | 6.4 | GO:0052697 | xenobiotic glucuronidation(GO:0052697) |
0.7 | 0.7 | GO:0035413 | positive regulation of catenin import into nucleus(GO:0035413) |
0.7 | 2.8 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
0.7 | 2.1 | GO:0060056 | mammary gland involution(GO:0060056) |
0.7 | 2.8 | GO:0060312 | regulation of blood vessel remodeling(GO:0060312) |
0.7 | 2.1 | GO:0046813 | receptor-mediated virion attachment to host cell(GO:0046813) |
0.7 | 0.7 | GO:0060231 | mesenchymal to epithelial transition(GO:0060231) |
0.7 | 0.7 | GO:0090241 | negative regulation of histone H4 acetylation(GO:0090241) |
0.7 | 0.7 | GO:0034441 | plasma lipoprotein particle oxidation(GO:0034441) |
0.7 | 2.1 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.7 | 1.4 | GO:1901979 | regulation of inward rectifier potassium channel activity(GO:1901979) |
0.7 | 6.9 | GO:0003334 | keratinocyte development(GO:0003334) |
0.7 | 2.8 | GO:0045918 | negative regulation of cytolysis(GO:0045918) |
0.7 | 9.6 | GO:0044130 | negative regulation of growth of symbiont in host(GO:0044130) negative regulation of growth of symbiont involved in interaction with host(GO:0044146) |
0.7 | 4.1 | GO:0015671 | oxygen transport(GO:0015671) |
0.7 | 0.7 | GO:0032415 | regulation of sodium:proton antiporter activity(GO:0032415) positive regulation of sodium:proton antiporter activity(GO:0032417) |
0.7 | 2.0 | GO:0043116 | negative regulation of vascular permeability(GO:0043116) |
0.7 | 11.4 | GO:0002026 | regulation of the force of heart contraction(GO:0002026) |
0.7 | 2.7 | GO:0090400 | stress-induced premature senescence(GO:0090400) |
0.7 | 2.0 | GO:0032439 | endosome localization(GO:0032439) |
0.7 | 2.0 | GO:0035697 | CD8-positive, alpha-beta T cell extravasation(GO:0035697) |
0.7 | 3.3 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.7 | 4.6 | GO:0016056 | rhodopsin mediated signaling pathway(GO:0016056) |
0.7 | 2.6 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
0.7 | 4.0 | GO:0070141 | response to UV-A(GO:0070141) |
0.7 | 2.0 | GO:0045713 | low-density lipoprotein particle receptor biosynthetic process(GO:0045713) |
0.7 | 2.6 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
0.7 | 5.9 | GO:0060561 | apoptotic process involved in morphogenesis(GO:0060561) |
0.7 | 1.3 | GO:0072061 | inner medullary collecting duct development(GO:0072061) |
0.6 | 1.9 | GO:2000359 | regulation of binding of sperm to zona pellucida(GO:2000359) |
0.6 | 0.6 | GO:0010881 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion(GO:0010881) |
0.6 | 1.3 | GO:0060100 | positive regulation of phagocytosis, engulfment(GO:0060100) positive regulation of membrane invagination(GO:1905155) |
0.6 | 0.6 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
0.6 | 3.2 | GO:0048012 | hepatocyte growth factor receptor signaling pathway(GO:0048012) |
0.6 | 31.1 | GO:0048704 | embryonic skeletal system morphogenesis(GO:0048704) |
0.6 | 1.3 | GO:0002159 | desmosome assembly(GO:0002159) |
0.6 | 2.5 | GO:0033629 | negative regulation of cell adhesion mediated by integrin(GO:0033629) |
0.6 | 0.6 | GO:2000017 | positive regulation of determination of dorsal identity(GO:2000017) |
0.6 | 1.9 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.6 | 3.1 | GO:0045110 | intermediate filament bundle assembly(GO:0045110) |
0.6 | 6.2 | GO:0002329 | pre-B cell differentiation(GO:0002329) |
0.6 | 1.2 | GO:0031284 | positive regulation of guanylate cyclase activity(GO:0031284) |
0.6 | 1.2 | GO:0060509 | Type I pneumocyte differentiation(GO:0060509) |
0.6 | 0.6 | GO:0060454 | positive regulation of gastric acid secretion(GO:0060454) |
0.6 | 8.0 | GO:0048016 | inositol phosphate-mediated signaling(GO:0048016) |
0.6 | 1.8 | GO:0038171 | cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
0.6 | 0.6 | GO:1903984 | regulation of TRAIL-activated apoptotic signaling pathway(GO:1903121) positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
0.6 | 0.6 | GO:0090032 | negative regulation of steroid hormone biosynthetic process(GO:0090032) |
0.6 | 5.4 | GO:0035428 | hexose transmembrane transport(GO:0035428) |
0.6 | 3.0 | GO:0043416 | regulation of skeletal muscle tissue regeneration(GO:0043416) |
0.6 | 1.2 | GO:0001834 | trophectodermal cell proliferation(GO:0001834) |
0.6 | 2.4 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.6 | 3.0 | GO:0006545 | glycine biosynthetic process(GO:0006545) |
0.6 | 1.8 | GO:0009093 | cysteine catabolic process(GO:0009093) L-cysteine catabolic process(GO:0019448) L-cysteine metabolic process(GO:0046439) |
0.6 | 1.8 | GO:0001777 | T cell homeostatic proliferation(GO:0001777) |
0.6 | 1.8 | GO:1903232 | melanosome assembly(GO:1903232) |
0.6 | 1.8 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
0.6 | 0.6 | GO:0036480 | neuron intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0036480) regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903376) |
0.6 | 1.7 | GO:0009240 | isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
0.6 | 1.7 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.6 | 1.2 | GO:0030167 | proteoglycan catabolic process(GO:0030167) |
0.6 | 0.6 | GO:0010002 | cardioblast differentiation(GO:0010002) |
0.6 | 0.6 | GO:0070293 | renal absorption(GO:0070293) |
0.6 | 2.3 | GO:0060045 | positive regulation of cardiac muscle cell proliferation(GO:0060045) |
0.6 | 1.1 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
0.6 | 0.6 | GO:2000053 | regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000053) negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000054) |
0.6 | 2.3 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
0.6 | 1.7 | GO:0045650 | negative regulation of macrophage differentiation(GO:0045650) |
0.6 | 0.6 | GO:0031282 | regulation of guanylate cyclase activity(GO:0031282) |
0.6 | 2.3 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
0.6 | 0.6 | GO:0046499 | S-adenosylmethioninamine metabolic process(GO:0046499) |
0.6 | 1.7 | GO:0046909 | intermembrane transport(GO:0046909) |
0.6 | 3.4 | GO:0051546 | keratinocyte migration(GO:0051546) |
0.6 | 2.3 | GO:2001260 | regulation of semaphorin-plexin signaling pathway(GO:2001260) |
0.6 | 1.7 | GO:2000794 | regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000794) |
0.6 | 11.8 | GO:0010595 | positive regulation of endothelial cell migration(GO:0010595) |
0.6 | 2.2 | GO:0034080 | CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
0.6 | 1.1 | GO:0044034 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
0.6 | 1.7 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
0.6 | 2.2 | GO:0035767 | endothelial cell chemotaxis(GO:0035767) |
0.6 | 2.8 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.6 | 1.1 | GO:1900086 | regulation of peptidyl-tyrosine autophosphorylation(GO:1900084) positive regulation of peptidyl-tyrosine autophosphorylation(GO:1900086) |
0.6 | 2.2 | GO:0032516 | positive regulation of phosphoprotein phosphatase activity(GO:0032516) |
0.6 | 0.6 | GO:0010694 | positive regulation of alkaline phosphatase activity(GO:0010694) |
0.6 | 1.1 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
0.6 | 0.6 | GO:0014056 | acetylcholine secretion, neurotransmission(GO:0014055) regulation of acetylcholine secretion, neurotransmission(GO:0014056) |
0.6 | 5.0 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
0.6 | 3.9 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.5 | 2.2 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
0.5 | 6.0 | GO:0015858 | nucleoside transport(GO:0015858) |
0.5 | 2.7 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
0.5 | 0.5 | GO:0050923 | regulation of negative chemotaxis(GO:0050923) |
0.5 | 5.5 | GO:0071545 | inositol phosphate catabolic process(GO:0071545) |
0.5 | 7.1 | GO:0014850 | response to muscle activity(GO:0014850) |
0.5 | 7.0 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
0.5 | 7.5 | GO:0043153 | entrainment of circadian clock by photoperiod(GO:0043153) |
0.5 | 1.6 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.5 | 4.8 | GO:0043306 | positive regulation of mast cell activation involved in immune response(GO:0033008) positive regulation of mast cell degranulation(GO:0043306) |
0.5 | 0.5 | GO:0036462 | TRAIL-activated apoptotic signaling pathway(GO:0036462) |
0.5 | 1.1 | GO:0001976 | neurological system process involved in regulation of systemic arterial blood pressure(GO:0001976) |
0.5 | 1.6 | GO:0086015 | SA node cell action potential(GO:0086015) SA node cell to atrial cardiac muscle cell signalling(GO:0086018) SA node cell to atrial cardiac muscle cell communication(GO:0086070) |
0.5 | 3.2 | GO:0070255 | regulation of mucus secretion(GO:0070255) |
0.5 | 2.6 | GO:0035810 | positive regulation of urine volume(GO:0035810) |
0.5 | 5.3 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.5 | 2.6 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.5 | 7.3 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.5 | 8.4 | GO:0050891 | multicellular organismal water homeostasis(GO:0050891) |
0.5 | 3.1 | GO:0060043 | regulation of cardiac muscle cell proliferation(GO:0060043) |
0.5 | 3.1 | GO:0003091 | renal water homeostasis(GO:0003091) |
0.5 | 0.5 | GO:0072198 | mesenchymal cell proliferation involved in ureter development(GO:0072198) regulation of mesenchymal cell proliferation involved in ureter development(GO:0072199) positive regulation of mesenchymal cell proliferation involved in ureter development(GO:2000729) |
0.5 | 0.5 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
0.5 | 2.1 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
0.5 | 2.0 | GO:0060907 | positive regulation of macrophage cytokine production(GO:0060907) |
0.5 | 0.5 | GO:0046878 | positive regulation of saliva secretion(GO:0046878) |
0.5 | 6.1 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
0.5 | 1.5 | GO:2000810 | regulation of bicellular tight junction assembly(GO:2000810) |
0.5 | 2.5 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.5 | 1.0 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.5 | 1.5 | GO:0072318 | clathrin coat disassembly(GO:0072318) |
0.5 | 0.5 | GO:0007440 | foregut morphogenesis(GO:0007440) |
0.5 | 0.5 | GO:0033159 | negative regulation of protein import into nucleus, translocation(GO:0033159) |
0.5 | 1.0 | GO:0042713 | sperm ejaculation(GO:0042713) |
0.5 | 2.0 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.5 | 2.9 | GO:0001502 | cartilage condensation(GO:0001502) cell aggregation(GO:0098743) |
0.5 | 1.0 | GO:0019344 | cysteine biosynthetic process(GO:0019344) |
0.5 | 0.5 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
0.5 | 3.9 | GO:0019511 | peptidyl-proline hydroxylation(GO:0019511) |
0.5 | 1.5 | GO:0006285 | base-excision repair, AP site formation(GO:0006285) |
0.5 | 4.3 | GO:0001829 | trophectodermal cell differentiation(GO:0001829) |
0.5 | 1.4 | GO:0031443 | fast-twitch skeletal muscle fiber contraction(GO:0031443) |
0.5 | 0.5 | GO:0003198 | epithelial to mesenchymal transition involved in endocardial cushion formation(GO:0003198) |
0.5 | 1.9 | GO:0060037 | pharyngeal system development(GO:0060037) |
0.5 | 1.4 | GO:0010759 | positive regulation of macrophage chemotaxis(GO:0010759) |
0.5 | 0.5 | GO:0030859 | polarized epithelial cell differentiation(GO:0030859) |
0.5 | 0.5 | GO:0033686 | positive regulation of luteinizing hormone secretion(GO:0033686) |
0.5 | 0.9 | GO:0070294 | renal sodium ion absorption(GO:0070294) |
0.5 | 0.9 | GO:0003383 | apical constriction(GO:0003383) |
0.5 | 1.9 | GO:0018101 | protein citrullination(GO:0018101) |
0.5 | 3.7 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
0.5 | 2.3 | GO:2000052 | positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
0.5 | 0.5 | GO:0007176 | regulation of epidermal growth factor-activated receptor activity(GO:0007176) |
0.5 | 0.5 | GO:0051593 | response to folic acid(GO:0051593) |
0.5 | 0.9 | GO:0045080 | positive regulation of chemokine biosynthetic process(GO:0045080) |
0.5 | 0.9 | GO:1901386 | negative regulation of voltage-gated calcium channel activity(GO:1901386) |
0.5 | 0.5 | GO:1900147 | Schwann cell migration(GO:0036135) regulation of Schwann cell migration(GO:1900147) positive regulation of glial cell migration(GO:1903977) |
0.5 | 1.4 | GO:0032725 | positive regulation of granulocyte macrophage colony-stimulating factor production(GO:0032725) |
0.5 | 1.4 | GO:0060023 | soft palate development(GO:0060023) |
0.5 | 0.9 | GO:1901550 | regulation of endothelial cell development(GO:1901550) regulation of establishment of endothelial barrier(GO:1903140) |
0.5 | 1.8 | GO:1903546 | protein localization to photoreceptor outer segment(GO:1903546) |
0.5 | 0.5 | GO:0003175 | tricuspid valve development(GO:0003175) |
0.5 | 3.6 | GO:0035813 | renal sodium excretion(GO:0035812) regulation of renal sodium excretion(GO:0035813) |
0.5 | 1.4 | GO:0033499 | galactose catabolic process via UDP-galactose(GO:0033499) glycolytic process from galactose(GO:0061623) |
0.5 | 3.6 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
0.5 | 0.5 | GO:1905048 | regulation of metallopeptidase activity(GO:1905048) |
0.5 | 0.5 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
0.5 | 3.2 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
0.5 | 2.7 | GO:0010216 | maintenance of DNA methylation(GO:0010216) |
0.4 | 1.8 | GO:0018214 | protein carboxylation(GO:0018214) |
0.4 | 1.8 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.4 | 2.7 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
0.4 | 0.9 | GO:0033030 | negative regulation of neutrophil apoptotic process(GO:0033030) |
0.4 | 1.3 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
0.4 | 0.4 | GO:0044332 | Wnt signaling pathway involved in dorsal/ventral axis specification(GO:0044332) |
0.4 | 0.4 | GO:2000384 | regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
0.4 | 0.9 | GO:0003179 | heart valve morphogenesis(GO:0003179) |
0.4 | 0.4 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
0.4 | 1.8 | GO:0019478 | D-amino acid catabolic process(GO:0019478) |
0.4 | 1.3 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.4 | 2.6 | GO:0002016 | regulation of blood volume by renin-angiotensin(GO:0002016) |
0.4 | 0.4 | GO:0007182 | common-partner SMAD protein phosphorylation(GO:0007182) |
0.4 | 1.8 | GO:0035795 | negative regulation of mitochondrial membrane permeability(GO:0035795) |
0.4 | 3.5 | GO:0051014 | actin filament severing(GO:0051014) |
0.4 | 2.6 | GO:0002024 | diet induced thermogenesis(GO:0002024) adaptive thermogenesis(GO:1990845) |
0.4 | 2.2 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
0.4 | 0.4 | GO:0031943 | regulation of glucocorticoid metabolic process(GO:0031943) |
0.4 | 4.3 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.4 | 6.0 | GO:1901185 | negative regulation of ERBB signaling pathway(GO:1901185) |
0.4 | 0.9 | GO:0030836 | positive regulation of actin filament depolymerization(GO:0030836) |
0.4 | 1.7 | GO:0030311 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.4 | 2.1 | GO:0042246 | tissue regeneration(GO:0042246) |
0.4 | 3.4 | GO:0006283 | transcription-coupled nucleotide-excision repair(GO:0006283) |
0.4 | 1.7 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.4 | 2.1 | GO:0061180 | mammary gland epithelium development(GO:0061180) |
0.4 | 0.8 | GO:0070561 | vitamin D receptor signaling pathway(GO:0070561) |
0.4 | 0.8 | GO:2000834 | androgen secretion(GO:0035935) regulation of androgen secretion(GO:2000834) positive regulation of androgen secretion(GO:2000836) |
0.4 | 2.1 | GO:0032224 | positive regulation of synaptic transmission, cholinergic(GO:0032224) |
0.4 | 2.5 | GO:0043518 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) |
0.4 | 2.9 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.4 | 1.7 | GO:0032466 | negative regulation of cytokinesis(GO:0032466) |
0.4 | 1.2 | GO:1900454 | positive regulation of long term synaptic depression(GO:1900454) |
0.4 | 0.8 | GO:0048597 | post-embryonic camera-type eye morphogenesis(GO:0048597) |
0.4 | 1.2 | GO:0006499 | N-terminal protein myristoylation(GO:0006499) |
0.4 | 1.2 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.4 | 11.1 | GO:0031424 | keratinization(GO:0031424) |
0.4 | 0.8 | GO:0007227 | signal transduction downstream of smoothened(GO:0007227) |
0.4 | 0.4 | GO:0097195 | pilomotor reflex(GO:0097195) |
0.4 | 0.4 | GO:0046985 | positive regulation of hemoglobin biosynthetic process(GO:0046985) |
0.4 | 1.2 | GO:0034653 | diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) |
0.4 | 2.0 | GO:2000344 | positive regulation of acrosome reaction(GO:2000344) |
0.4 | 2.4 | GO:0010717 | regulation of epithelial to mesenchymal transition(GO:0010717) |
0.4 | 0.8 | GO:0060167 | regulation of adenosine receptor signaling pathway(GO:0060167) |
0.4 | 3.2 | GO:0071260 | cellular response to mechanical stimulus(GO:0071260) |
0.4 | 1.6 | GO:0007398 | ectoderm development(GO:0007398) |
0.4 | 7.2 | GO:0048706 | embryonic skeletal system development(GO:0048706) |
0.4 | 1.2 | GO:0001757 | somite specification(GO:0001757) |
0.4 | 1.2 | GO:0036233 | glycine import(GO:0036233) |
0.4 | 0.8 | GO:2001184 | positive regulation of interleukin-12 secretion(GO:2001184) |
0.4 | 1.2 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
0.4 | 3.6 | GO:0010718 | positive regulation of epithelial to mesenchymal transition(GO:0010718) |
0.4 | 0.4 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.4 | 0.8 | GO:0015705 | iodide transport(GO:0015705) |
0.4 | 0.4 | GO:0060525 | prostate glandular acinus development(GO:0060525) |
0.4 | 0.4 | GO:0051541 | elastin metabolic process(GO:0051541) |
0.4 | 3.1 | GO:0015809 | arginine transport(GO:0015809) |
0.4 | 1.6 | GO:0045990 | carbon catabolite regulation of transcription(GO:0045990) |
0.4 | 0.4 | GO:0035729 | response to hepatocyte growth factor(GO:0035728) cellular response to hepatocyte growth factor stimulus(GO:0035729) |
0.4 | 7.3 | GO:0003009 | skeletal muscle contraction(GO:0003009) |
0.4 | 1.2 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
0.4 | 0.4 | GO:0071169 | establishment of protein localization to chromatin(GO:0071169) |
0.4 | 0.4 | GO:0033087 | negative regulation of immature T cell proliferation(GO:0033087) |
0.4 | 1.1 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
0.4 | 1.5 | GO:1903012 | positive regulation of bone development(GO:1903012) |
0.4 | 2.3 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
0.4 | 1.1 | GO:0032495 | response to muramyl dipeptide(GO:0032495) |
0.4 | 1.5 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
0.4 | 8.2 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
0.4 | 1.1 | GO:0035521 | monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
0.4 | 1.1 | GO:0048385 | regulation of retinoic acid receptor signaling pathway(GO:0048385) |
0.4 | 1.1 | GO:0009649 | entrainment of circadian clock(GO:0009649) |
0.4 | 0.7 | GO:0006068 | ethanol catabolic process(GO:0006068) |
0.4 | 1.1 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.4 | 0.4 | GO:0002691 | regulation of cellular extravasation(GO:0002691) |
0.4 | 0.7 | GO:0060437 | lung growth(GO:0060437) |
0.4 | 1.8 | GO:0090026 | positive regulation of monocyte chemotaxis(GO:0090026) |
0.4 | 0.4 | GO:0030423 | targeting of mRNA for destruction involved in RNA interference(GO:0030423) |
0.4 | 1.8 | GO:1902510 | regulation of apoptotic DNA fragmentation(GO:1902510) |
0.4 | 1.5 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
0.4 | 1.8 | GO:0048384 | retinoic acid receptor signaling pathway(GO:0048384) |
0.4 | 0.4 | GO:0050711 | negative regulation of interleukin-1 secretion(GO:0050711) |
0.4 | 1.4 | GO:0033689 | negative regulation of osteoblast proliferation(GO:0033689) |
0.4 | 0.7 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
0.4 | 3.2 | GO:0007135 | meiosis II(GO:0007135) |
0.4 | 1.4 | GO:0043031 | negative regulation of macrophage activation(GO:0043031) |
0.4 | 1.8 | GO:0045651 | positive regulation of macrophage differentiation(GO:0045651) |
0.4 | 1.4 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
0.4 | 0.7 | GO:0014857 | regulation of skeletal muscle cell proliferation(GO:0014857) |
0.4 | 1.1 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.4 | 0.7 | GO:2000288 | positive regulation of myoblast proliferation(GO:2000288) |
0.4 | 0.7 | GO:0030421 | defecation(GO:0030421) |
0.4 | 0.7 | GO:1900452 | regulation of long term synaptic depression(GO:1900452) |
0.4 | 1.4 | GO:1905038 | regulation of sphingolipid biosynthetic process(GO:0090153) regulation of membrane lipid metabolic process(GO:1905038) |
0.4 | 0.4 | GO:0042487 | regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
0.3 | 0.7 | GO:0001983 | baroreceptor response to increased systemic arterial blood pressure(GO:0001983) |
0.3 | 2.1 | GO:0001837 | epithelial to mesenchymal transition(GO:0001837) |
0.3 | 0.7 | GO:0030916 | otic vesicle formation(GO:0030916) |
0.3 | 1.4 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
0.3 | 0.7 | GO:0060084 | synaptic transmission involved in micturition(GO:0060084) |
0.3 | 0.7 | GO:0014733 | regulation of skeletal muscle adaptation(GO:0014733) |
0.3 | 1.0 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
0.3 | 0.3 | GO:1903899 | positive regulation of PERK-mediated unfolded protein response(GO:1903899) |
0.3 | 0.3 | GO:0060632 | regulation of microtubule-based movement(GO:0060632) |
0.3 | 3.8 | GO:0030318 | melanocyte differentiation(GO:0030318) |
0.3 | 0.7 | GO:0070827 | chromatin maintenance(GO:0070827) |
0.3 | 1.0 | GO:1904528 | regulation of microtubule binding(GO:1904526) positive regulation of microtubule binding(GO:1904528) |
0.3 | 0.7 | GO:0021940 | positive regulation of cerebellar granule cell precursor proliferation(GO:0021940) |
0.3 | 0.3 | GO:0071372 | response to follicle-stimulating hormone(GO:0032354) cellular response to follicle-stimulating hormone stimulus(GO:0071372) |
0.3 | 1.0 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
0.3 | 1.0 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.3 | 1.0 | GO:0060688 | regulation of morphogenesis of a branching structure(GO:0060688) |
0.3 | 1.7 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
0.3 | 0.7 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
0.3 | 1.3 | GO:0061299 | retina vasculature morphogenesis in camera-type eye(GO:0061299) |
0.3 | 0.7 | GO:0071799 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
0.3 | 0.3 | GO:0046880 | regulation of follicle-stimulating hormone secretion(GO:0046880) |
0.3 | 1.0 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
0.3 | 0.7 | GO:0050961 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
0.3 | 0.7 | GO:0034472 | snRNA 3'-end processing(GO:0034472) |
0.3 | 1.0 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.3 | 1.3 | GO:0046602 | regulation of mitotic centrosome separation(GO:0046602) |
0.3 | 2.9 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
0.3 | 0.3 | GO:0016539 | intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) |
0.3 | 1.6 | GO:0002087 | regulation of respiratory gaseous exchange by neurological system process(GO:0002087) |
0.3 | 1.0 | GO:0036289 | peptidyl-serine autophosphorylation(GO:0036289) |
0.3 | 1.6 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.3 | 0.6 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
0.3 | 3.5 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.3 | 1.3 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
0.3 | 1.9 | GO:1901678 | iron coordination entity transport(GO:1901678) |
0.3 | 1.6 | GO:0046621 | negative regulation of organ growth(GO:0046621) |
0.3 | 0.3 | GO:2000698 | positive regulation of epithelial cell differentiation involved in kidney development(GO:2000698) |
0.3 | 3.1 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
0.3 | 0.6 | GO:0002765 | immune response-inhibiting signal transduction(GO:0002765) |
0.3 | 2.5 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
0.3 | 1.2 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.3 | 1.6 | GO:0048566 | embryonic digestive tract development(GO:0048566) |
0.3 | 2.5 | GO:0051085 | chaperone mediated protein folding requiring cofactor(GO:0051085) |
0.3 | 0.9 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
0.3 | 1.2 | GO:0070989 | oxidative demethylation(GO:0070989) |
0.3 | 0.3 | GO:0048014 | Tie signaling pathway(GO:0048014) |
0.3 | 0.9 | GO:0060050 | positive regulation of protein glycosylation(GO:0060050) |
0.3 | 1.2 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
0.3 | 0.6 | GO:0051385 | response to mineralocorticoid(GO:0051385) |
0.3 | 3.6 | GO:0002385 | organ or tissue specific immune response(GO:0002251) mucosal immune response(GO:0002385) |
0.3 | 0.9 | GO:0035524 | proline transmembrane transport(GO:0035524) |
0.3 | 1.8 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.3 | 0.9 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
0.3 | 0.3 | GO:0014016 | neuroblast differentiation(GO:0014016) |
0.3 | 0.3 | GO:0016048 | detection of temperature stimulus(GO:0016048) |
0.3 | 0.6 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
0.3 | 2.4 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.3 | 1.2 | GO:0036481 | intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:0036481) |
0.3 | 0.3 | GO:0009826 | unidimensional cell growth(GO:0009826) |
0.3 | 1.2 | GO:1990414 | replication-born double-strand break repair via sister chromatid exchange(GO:1990414) |
0.3 | 0.3 | GO:0023041 | neuronal signal transduction(GO:0023041) |
0.3 | 3.5 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
0.3 | 1.7 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.3 | 0.6 | GO:0032071 | regulation of endodeoxyribonuclease activity(GO:0032071) |
0.3 | 0.9 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
0.3 | 0.6 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
0.3 | 3.7 | GO:0051898 | negative regulation of protein kinase B signaling(GO:0051898) |
0.3 | 0.3 | GO:0045627 | positive regulation of T-helper 1 cell differentiation(GO:0045627) |
0.3 | 1.1 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.3 | 1.1 | GO:0001954 | positive regulation of cell-matrix adhesion(GO:0001954) |
0.3 | 0.3 | GO:0060620 | regulation of cholesterol import(GO:0060620) regulation of sterol import(GO:2000909) |
0.3 | 1.4 | GO:0034227 | tRNA thio-modification(GO:0034227) |
0.3 | 0.3 | GO:0090230 | regulation of centromere complex assembly(GO:0090230) |
0.3 | 0.3 | GO:0035701 | hematopoietic stem cell migration(GO:0035701) |
0.3 | 0.8 | GO:2000647 | negative regulation of stem cell proliferation(GO:2000647) |
0.3 | 0.8 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
0.3 | 0.3 | GO:2000097 | regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
0.3 | 0.3 | GO:0045404 | positive regulation of interleukin-4 biosynthetic process(GO:0045404) |
0.3 | 0.8 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
0.3 | 1.4 | GO:0061298 | retina vasculature development in camera-type eye(GO:0061298) |
0.3 | 0.8 | GO:0097680 | double-strand break repair via classical nonhomologous end joining(GO:0097680) |
0.3 | 0.3 | GO:0042695 | thelarche(GO:0042695) mammary gland branching involved in thelarche(GO:0060744) |
0.3 | 0.8 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.3 | 5.0 | GO:0055013 | cardiac muscle cell development(GO:0055013) |
0.3 | 0.3 | GO:0001555 | oocyte growth(GO:0001555) |
0.3 | 2.2 | GO:0071880 | adenylate cyclase-activating adrenergic receptor signaling pathway(GO:0071880) |
0.3 | 0.3 | GO:0060502 | epithelial cell proliferation involved in lung morphogenesis(GO:0060502) regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903798) positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
0.3 | 0.3 | GO:1990036 | calcium ion import into sarcoplasmic reticulum(GO:1990036) |
0.3 | 3.0 | GO:0000479 | endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000479) |
0.3 | 0.3 | GO:0002125 | maternal aggressive behavior(GO:0002125) |
0.3 | 0.5 | GO:0043950 | positive regulation of cAMP-mediated signaling(GO:0043950) |
0.3 | 0.3 | GO:0045986 | negative regulation of smooth muscle contraction(GO:0045986) |
0.3 | 1.6 | GO:0043403 | skeletal muscle tissue regeneration(GO:0043403) |
0.3 | 0.8 | GO:0046469 | platelet activating factor biosynthetic process(GO:0006663) platelet activating factor metabolic process(GO:0046469) |
0.3 | 1.1 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
0.3 | 0.5 | GO:0044062 | regulation of excretion(GO:0044062) |
0.3 | 0.8 | GO:0045585 | regulation of cytotoxic T cell differentiation(GO:0045583) positive regulation of cytotoxic T cell differentiation(GO:0045585) |
0.3 | 0.3 | GO:1902606 | regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) |
0.3 | 0.5 | GO:1902953 | positive regulation of ER to Golgi vesicle-mediated transport(GO:1902953) |
0.3 | 1.1 | GO:0071033 | nuclear retention of pre-mRNA at the site of transcription(GO:0071033) |
0.3 | 1.1 | GO:0038092 | nodal signaling pathway(GO:0038092) |
0.3 | 0.5 | GO:0071351 | response to interleukin-18(GO:0070673) cellular response to interleukin-18(GO:0071351) |
0.3 | 0.3 | GO:0035898 | parathyroid hormone secretion(GO:0035898) |
0.3 | 0.5 | GO:0042636 | negative regulation of hair cycle(GO:0042636) |
0.3 | 2.6 | GO:0097186 | amelogenesis(GO:0097186) |
0.3 | 4.2 | GO:0010569 | regulation of double-strand break repair via homologous recombination(GO:0010569) |
0.3 | 0.8 | GO:2000680 | regulation of rubidium ion transport(GO:2000680) |
0.3 | 5.5 | GO:0009268 | response to pH(GO:0009268) |
0.3 | 1.0 | GO:0048733 | sebaceous gland development(GO:0048733) |
0.3 | 1.8 | GO:0014041 | regulation of neuron maturation(GO:0014041) |
0.3 | 0.3 | GO:0060061 | Spemann organizer formation(GO:0060061) |
0.3 | 1.6 | GO:0001886 | endothelial cell morphogenesis(GO:0001886) |
0.3 | 2.3 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
0.3 | 0.8 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
0.3 | 0.5 | GO:0048570 | notochord morphogenesis(GO:0048570) |
0.3 | 0.3 | GO:0006714 | sesquiterpenoid metabolic process(GO:0006714) |
0.3 | 0.8 | GO:0061370 | testosterone biosynthetic process(GO:0061370) |
0.3 | 0.3 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
0.3 | 0.3 | GO:0034633 | retinol transport(GO:0034633) isoprenoid transport(GO:0046864) terpenoid transport(GO:0046865) |
0.3 | 0.3 | GO:1903204 | negative regulation of oxidative stress-induced neuron death(GO:1903204) |
0.3 | 0.3 | GO:0061162 | establishment of monopolar cell polarity(GO:0061162) establishment or maintenance of monopolar cell polarity(GO:0061339) |
0.3 | 0.3 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
0.3 | 0.8 | GO:0032691 | negative regulation of interleukin-1 beta production(GO:0032691) |
0.3 | 0.5 | GO:0071027 | nuclear RNA surveillance(GO:0071027) nuclear mRNA surveillance(GO:0071028) |
0.3 | 0.5 | GO:0002924 | negative regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002924) |
0.3 | 1.3 | GO:0090051 | negative regulation of cell migration involved in sprouting angiogenesis(GO:0090051) |
0.2 | 0.2 | GO:0007571 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
0.2 | 0.7 | GO:0036035 | osteoclast development(GO:0036035) |
0.2 | 1.2 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.2 | 0.7 | GO:1900095 | regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
0.2 | 1.2 | GO:2000251 | positive regulation of actin cytoskeleton reorganization(GO:2000251) |
0.2 | 2.0 | GO:0032735 | positive regulation of interleukin-12 production(GO:0032735) |
0.2 | 0.2 | GO:0046655 | folic acid metabolic process(GO:0046655) |
0.2 | 0.2 | GO:0035990 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
0.2 | 0.5 | GO:0010635 | regulation of mitochondrial fusion(GO:0010635) |
0.2 | 0.7 | GO:0048631 | regulation of skeletal muscle tissue growth(GO:0048631) |
0.2 | 1.0 | GO:0045616 | regulation of keratinocyte differentiation(GO:0045616) |
0.2 | 0.2 | GO:0071670 | smooth muscle cell chemotaxis(GO:0071670) |
0.2 | 0.5 | GO:0046543 | development of secondary female sexual characteristics(GO:0046543) |
0.2 | 0.2 | GO:0045590 | negative regulation of regulatory T cell differentiation(GO:0045590) |
0.2 | 2.1 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.2 | 0.5 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
0.2 | 0.7 | GO:0060340 | positive regulation of type I interferon-mediated signaling pathway(GO:0060340) |
0.2 | 0.2 | GO:0009996 | negative regulation of cell fate specification(GO:0009996) |
0.2 | 1.2 | GO:0070070 | proton-transporting V-type ATPase complex assembly(GO:0070070) |
0.2 | 0.9 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
0.2 | 0.9 | GO:0002786 | regulation of antimicrobial peptide production(GO:0002784) regulation of antibacterial peptide production(GO:0002786) |
0.2 | 1.4 | GO:0016322 | neuron remodeling(GO:0016322) |
0.2 | 0.2 | GO:0003207 | cardiac chamber formation(GO:0003207) |
0.2 | 0.7 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.2 | 0.2 | GO:0021855 | hypothalamus cell migration(GO:0021855) |
0.2 | 0.5 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
0.2 | 0.5 | GO:0002540 | leukotriene production involved in inflammatory response(GO:0002540) |
0.2 | 1.1 | GO:2000188 | regulation of cholesterol homeostasis(GO:2000188) |
0.2 | 1.4 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
0.2 | 1.1 | GO:1904970 | brush border assembly(GO:1904970) |
0.2 | 0.7 | GO:0002756 | MyD88-independent toll-like receptor signaling pathway(GO:0002756) |
0.2 | 2.1 | GO:0033617 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
0.2 | 0.5 | GO:1903261 | regulation of serine phosphorylation of STAT3 protein(GO:1903261) |
0.2 | 0.9 | GO:0002318 | myeloid progenitor cell differentiation(GO:0002318) |
0.2 | 0.7 | GO:0006116 | NADH oxidation(GO:0006116) |
0.2 | 0.2 | GO:0061526 | acetylcholine secretion(GO:0061526) |
0.2 | 0.9 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.2 | 2.5 | GO:0048714 | positive regulation of oligodendrocyte differentiation(GO:0048714) |
0.2 | 1.6 | GO:0030239 | myofibril assembly(GO:0030239) |
0.2 | 2.7 | GO:0051496 | positive regulation of stress fiber assembly(GO:0051496) |
0.2 | 0.7 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
0.2 | 0.2 | GO:0072189 | ureter development(GO:0072189) |
0.2 | 2.0 | GO:0000042 | protein targeting to Golgi(GO:0000042) |
0.2 | 0.2 | GO:2000275 | regulation of oxidative phosphorylation uncoupler activity(GO:2000275) |
0.2 | 1.3 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.2 | 0.2 | GO:0009648 | photoperiodism(GO:0009648) |
0.2 | 0.7 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.2 | 2.4 | GO:0034389 | lipid particle organization(GO:0034389) |
0.2 | 1.7 | GO:0021854 | hypothalamus development(GO:0021854) |
0.2 | 1.5 | GO:0015825 | L-serine transport(GO:0015825) |
0.2 | 0.4 | GO:0071866 | regulation of apoptotic process in bone marrow(GO:0071865) negative regulation of apoptotic process in bone marrow(GO:0071866) |
0.2 | 0.6 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
0.2 | 0.4 | GO:0010812 | negative regulation of cell-substrate adhesion(GO:0010812) |
0.2 | 0.4 | GO:0043921 | modulation by host of viral transcription(GO:0043921) positive regulation by host of viral transcription(GO:0043923) modulation of transcription in other organism involved in symbiotic interaction(GO:0052312) modulation by host of symbiont transcription(GO:0052472) |
0.2 | 2.5 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.2 | 1.3 | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
0.2 | 1.0 | GO:0010613 | positive regulation of cardiac muscle hypertrophy(GO:0010613) positive regulation of muscle hypertrophy(GO:0014742) |
0.2 | 0.4 | GO:0042374 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
0.2 | 1.4 | GO:0034427 | nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'(GO:0034427) |
0.2 | 0.4 | GO:0060155 | platelet dense granule organization(GO:0060155) |
0.2 | 0.2 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
0.2 | 4.3 | GO:0045103 | intermediate filament-based process(GO:0045103) |
0.2 | 0.8 | GO:0008211 | glucocorticoid metabolic process(GO:0008211) |
0.2 | 0.2 | GO:0035747 | natural killer cell chemotaxis(GO:0035747) regulation of natural killer cell chemotaxis(GO:2000501) |
0.2 | 0.2 | GO:1900738 | positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
0.2 | 0.4 | GO:1900368 | regulation of RNA interference(GO:1900368) |
0.2 | 0.6 | GO:0098532 | histone H3-K27 trimethylation(GO:0098532) |
0.2 | 0.8 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.2 | 0.4 | GO:1904668 | positive regulation of ubiquitin protein ligase activity(GO:1904668) |
0.2 | 0.8 | GO:0031340 | positive regulation of vesicle fusion(GO:0031340) |
0.2 | 0.4 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
0.2 | 1.0 | GO:0032967 | positive regulation of collagen biosynthetic process(GO:0032967) |
0.2 | 0.4 | GO:0042045 | epithelial fluid transport(GO:0042045) |
0.2 | 2.8 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.2 | 0.6 | GO:1904378 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
0.2 | 0.6 | GO:0045541 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
0.2 | 2.6 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.2 | 1.8 | GO:0070306 | lens fiber cell differentiation(GO:0070306) |
0.2 | 1.0 | GO:0010830 | regulation of myotube differentiation(GO:0010830) |
0.2 | 0.6 | GO:0014820 | tonic smooth muscle contraction(GO:0014820) |
0.2 | 0.2 | GO:0060390 | regulation of SMAD protein import into nucleus(GO:0060390) |
0.2 | 0.8 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
0.2 | 1.0 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
0.2 | 0.2 | GO:2000852 | corticosterone secretion(GO:0035934) regulation of corticosterone secretion(GO:2000852) |
0.2 | 0.6 | GO:0032201 | telomere maintenance via semi-conservative replication(GO:0032201) |
0.2 | 0.8 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.2 | 0.4 | GO:1901838 | positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901838) |
0.2 | 1.9 | GO:0048678 | response to axon injury(GO:0048678) |
0.2 | 0.4 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.2 | 0.2 | GO:0061743 | motor learning(GO:0061743) |
0.2 | 0.4 | GO:1901096 | regulation of autophagosome maturation(GO:1901096) |
0.2 | 0.6 | GO:0009972 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
0.2 | 1.9 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.2 | 0.7 | GO:0042756 | drinking behavior(GO:0042756) |
0.2 | 0.2 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.2 | 2.6 | GO:0048247 | lymphocyte chemotaxis(GO:0048247) |
0.2 | 1.8 | GO:0045742 | positive regulation of epidermal growth factor receptor signaling pathway(GO:0045742) positive regulation of ERBB signaling pathway(GO:1901186) |
0.2 | 0.2 | GO:0042998 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
0.2 | 0.4 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.2 | 0.5 | GO:0001927 | exocyst assembly(GO:0001927) |
0.2 | 0.5 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
0.2 | 0.7 | GO:2000252 | negative regulation of feeding behavior(GO:2000252) |
0.2 | 0.2 | GO:0007354 | zygotic determination of anterior/posterior axis, embryo(GO:0007354) |
0.2 | 0.5 | GO:1902715 | positive regulation of interferon-gamma secretion(GO:1902715) |
0.2 | 0.2 | GO:0042693 | muscle cell fate commitment(GO:0042693) |
0.2 | 0.2 | GO:0060371 | regulation of atrial cardiac muscle cell membrane depolarization(GO:0060371) |
0.2 | 0.4 | GO:1902309 | negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
0.2 | 0.4 | GO:2000404 | regulation of T cell migration(GO:2000404) |
0.2 | 0.5 | GO:0097210 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
0.2 | 0.5 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) |
0.2 | 1.2 | GO:0014002 | astrocyte development(GO:0014002) |
0.2 | 0.2 | GO:1900019 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
0.2 | 0.4 | GO:2000535 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
0.2 | 0.5 | GO:0035964 | COPI-coated vesicle budding(GO:0035964) |
0.2 | 0.2 | GO:0038001 | paracrine signaling(GO:0038001) |
0.2 | 1.7 | GO:0010831 | positive regulation of myotube differentiation(GO:0010831) |
0.2 | 0.5 | GO:2000010 | positive regulation of protein localization to cell surface(GO:2000010) |
0.2 | 0.2 | GO:0010982 | regulation of high-density lipoprotein particle clearance(GO:0010982) |
0.2 | 0.2 | GO:0003413 | chondrocyte differentiation involved in endochondral bone morphogenesis(GO:0003413) |
0.2 | 0.2 | GO:1902513 | regulation of organelle transport along microtubule(GO:1902513) |
0.2 | 0.2 | GO:0009642 | response to light intensity(GO:0009642) |
0.2 | 0.2 | GO:2001182 | regulation of interleukin-12 secretion(GO:2001182) |
0.2 | 0.5 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
0.2 | 0.7 | GO:0009624 | response to nematode(GO:0009624) |
0.2 | 1.3 | GO:2000479 | regulation of cAMP-dependent protein kinase activity(GO:2000479) |
0.2 | 0.3 | GO:0006562 | proline catabolic process(GO:0006562) |
0.2 | 0.7 | GO:0001771 | immunological synapse formation(GO:0001771) |
0.2 | 0.3 | GO:0051492 | regulation of stress fiber assembly(GO:0051492) |
0.2 | 0.7 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
0.2 | 0.5 | GO:0032594 | protein transport within lipid bilayer(GO:0032594) |
0.2 | 0.3 | GO:0045356 | positive regulation of interferon-alpha biosynthetic process(GO:0045356) |
0.2 | 0.5 | GO:0060707 | trophoblast giant cell differentiation(GO:0060707) |
0.2 | 0.3 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
0.2 | 2.6 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
0.2 | 0.5 | GO:0021873 | forebrain neuroblast division(GO:0021873) |
0.2 | 0.5 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.2 | 0.2 | GO:0034650 | cortisol metabolic process(GO:0034650) |
0.2 | 0.3 | GO:0042532 | negative regulation of tyrosine phosphorylation of STAT protein(GO:0042532) |
0.2 | 1.1 | GO:0006108 | malate metabolic process(GO:0006108) |
0.2 | 0.3 | GO:0061355 | Wnt protein secretion(GO:0061355) regulation of Wnt protein secretion(GO:0061356) |
0.2 | 0.5 | GO:0045198 | establishment of epithelial cell apical/basal polarity(GO:0045198) |
0.2 | 0.3 | GO:0071276 | cellular response to cadmium ion(GO:0071276) |
0.2 | 1.7 | GO:0042347 | negative regulation of NF-kappaB import into nucleus(GO:0042347) |
0.2 | 1.0 | GO:0048311 | mitochondrion distribution(GO:0048311) |
0.2 | 1.3 | GO:2000398 | regulation of T cell differentiation in thymus(GO:0033081) regulation of thymocyte aggregation(GO:2000398) |
0.2 | 0.8 | GO:0001878 | response to yeast(GO:0001878) |
0.2 | 0.3 | GO:0042628 | mating plug formation(GO:0042628) single-organism reproductive behavior(GO:0044704) post-mating behavior(GO:0045297) |
0.2 | 0.5 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.2 | 0.3 | GO:0015744 | succinate transport(GO:0015744) |
0.2 | 0.2 | GO:0021898 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment(GO:0021882) commitment of multipotent stem cells to neuronal lineage in forebrain(GO:0021898) |
0.2 | 3.2 | GO:0033619 | membrane protein proteolysis(GO:0033619) |
0.2 | 0.5 | GO:0070932 | histone H3 deacetylation(GO:0070932) |
0.2 | 0.3 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.2 | 0.5 | GO:0016553 | adenosine to inosine editing(GO:0006382) base conversion or substitution editing(GO:0016553) |
0.2 | 0.2 | GO:2000259 | positive regulation of complement activation(GO:0045917) positive regulation of protein activation cascade(GO:2000259) |
0.2 | 0.3 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
0.2 | 0.3 | GO:0043307 | eosinophil activation involved in immune response(GO:0002278) eosinophil mediated immunity(GO:0002447) eosinophil activation(GO:0043307) eosinophil degranulation(GO:0043308) |
0.2 | 0.3 | GO:2000327 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
0.1 | 0.6 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
0.1 | 0.1 | GO:0070318 | positive regulation of G0 to G1 transition(GO:0070318) |
0.1 | 0.1 | GO:0033031 | positive regulation of neutrophil apoptotic process(GO:0033031) |
0.1 | 1.6 | GO:0018027 | peptidyl-lysine dimethylation(GO:0018027) |
0.1 | 0.7 | GO:0010898 | positive regulation of triglyceride catabolic process(GO:0010898) |
0.1 | 0.1 | GO:1900242 | regulation of synaptic vesicle endocytosis(GO:1900242) |
0.1 | 0.7 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
0.1 | 0.1 | GO:1900378 | positive regulation of melanin biosynthetic process(GO:0048023) positive regulation of secondary metabolite biosynthetic process(GO:1900378) |
0.1 | 2.2 | GO:1903845 | negative regulation of transforming growth factor beta receptor signaling pathway(GO:0030512) negative regulation of cellular response to transforming growth factor beta stimulus(GO:1903845) |
0.1 | 0.4 | GO:0002827 | positive regulation of T-helper 1 type immune response(GO:0002827) |
0.1 | 1.4 | GO:0090220 | chromosome localization to nuclear envelope involved in homologous chromosome segregation(GO:0090220) |
0.1 | 0.1 | GO:0001759 | organ induction(GO:0001759) |
0.1 | 0.3 | GO:0090237 | regulation of arachidonic acid secretion(GO:0090237) |
0.1 | 1.1 | GO:0006907 | pinocytosis(GO:0006907) |
0.1 | 0.1 | GO:0070099 | regulation of chemokine-mediated signaling pathway(GO:0070099) |
0.1 | 1.8 | GO:0001892 | embryonic placenta development(GO:0001892) |
0.1 | 0.3 | GO:0006549 | isoleucine metabolic process(GO:0006549) |
0.1 | 0.1 | GO:0010454 | negative regulation of cell fate commitment(GO:0010454) |
0.1 | 0.8 | GO:0003352 | regulation of cilium movement(GO:0003352) |
0.1 | 1.1 | GO:0051974 | negative regulation of telomerase activity(GO:0051974) |
0.1 | 1.5 | GO:0007229 | integrin-mediated signaling pathway(GO:0007229) |
0.1 | 0.1 | GO:1902237 | positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902237) |
0.1 | 0.4 | GO:0032485 | regulation of Ral protein signal transduction(GO:0032485) |
0.1 | 0.8 | GO:0032366 | intracellular sterol transport(GO:0032366) |
0.1 | 0.7 | GO:1904357 | negative regulation of telomere maintenance via telomere lengthening(GO:1904357) |
0.1 | 0.1 | GO:0050872 | white fat cell differentiation(GO:0050872) |
0.1 | 0.7 | GO:0046836 | glycolipid transport(GO:0046836) |
0.1 | 0.1 | GO:0000237 | leptotene(GO:0000237) |
0.1 | 0.1 | GO:0010847 | regulation of chromatin assembly(GO:0010847) |
0.1 | 0.5 | GO:0045943 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
0.1 | 1.4 | GO:0045907 | positive regulation of vasoconstriction(GO:0045907) |
0.1 | 1.0 | GO:0035999 | tetrahydrofolate interconversion(GO:0035999) |
0.1 | 0.1 | GO:0003072 | regulation of blood vessel size by renin-angiotensin(GO:0002034) renal control of peripheral vascular resistance involved in regulation of systemic arterial blood pressure(GO:0003072) |
0.1 | 0.1 | GO:0061450 | trophoblast cell migration(GO:0061450) |
0.1 | 2.0 | GO:0035058 | nonmotile primary cilium assembly(GO:0035058) |
0.1 | 0.4 | GO:0010529 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
0.1 | 0.1 | GO:0051182 | coenzyme transport(GO:0051182) |
0.1 | 1.4 | GO:0036260 | 7-methylguanosine RNA capping(GO:0009452) RNA capping(GO:0036260) |
0.1 | 1.6 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
0.1 | 0.1 | GO:0019660 | fermentation(GO:0006113) glucose catabolic process to lactate(GO:0019659) glycolytic fermentation(GO:0019660) glucose catabolic process to lactate via pyruvate(GO:0019661) |
0.1 | 0.2 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.1 | 0.1 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
0.1 | 0.2 | GO:2000035 | regulation of stem cell division(GO:2000035) |
0.1 | 0.1 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
0.1 | 0.6 | GO:0036010 | protein localization to endosome(GO:0036010) |
0.1 | 0.1 | GO:0007060 | male meiosis chromosome segregation(GO:0007060) |
0.1 | 0.1 | GO:0045448 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
0.1 | 0.4 | GO:0046104 | thymidine metabolic process(GO:0046104) |
0.1 | 0.1 | GO:0097694 | establishment of RNA localization to telomere(GO:0097694) |
0.1 | 0.5 | GO:0033004 | negative regulation of mast cell activation(GO:0033004) |
0.1 | 0.1 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.1 | 0.8 | GO:0006346 | methylation-dependent chromatin silencing(GO:0006346) |
0.1 | 0.5 | GO:0043949 | regulation of cAMP-mediated signaling(GO:0043949) |
0.1 | 0.1 | GO:0097709 | connective tissue replacement involved in inflammatory response wound healing(GO:0002248) connective tissue replacement(GO:0097709) |
0.1 | 2.4 | GO:0050829 | defense response to Gram-negative bacterium(GO:0050829) |
0.1 | 0.2 | GO:0010520 | regulation of reciprocal meiotic recombination(GO:0010520) |
0.1 | 1.2 | GO:0050892 | intestinal absorption(GO:0050892) |
0.1 | 0.2 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
0.1 | 0.3 | GO:1902775 | mitochondrial large ribosomal subunit assembly(GO:1902775) |
0.1 | 0.7 | GO:0007614 | short-term memory(GO:0007614) |
0.1 | 0.9 | GO:0007520 | myoblast fusion(GO:0007520) |
0.1 | 0.1 | GO:0031953 | negative regulation of protein autophosphorylation(GO:0031953) |
0.1 | 0.9 | GO:0021889 | olfactory bulb interneuron differentiation(GO:0021889) |
0.1 | 8.8 | GO:0007266 | Rho protein signal transduction(GO:0007266) |
0.1 | 4.5 | GO:0007160 | cell-matrix adhesion(GO:0007160) |
0.1 | 1.6 | GO:0008272 | sulfate transport(GO:0008272) |
0.1 | 0.4 | GO:0006012 | galactose metabolic process(GO:0006012) |
0.1 | 0.6 | GO:0014009 | glial cell proliferation(GO:0014009) |
0.1 | 0.1 | GO:0021524 | visceral motor neuron differentiation(GO:0021524) |
0.1 | 2.8 | GO:0061077 | chaperone-mediated protein folding(GO:0061077) |
0.1 | 0.7 | GO:0002504 | antigen processing and presentation of peptide antigen via MHC class II(GO:0002495) antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002504) |
0.1 | 1.2 | GO:2001015 | negative regulation of skeletal muscle cell differentiation(GO:2001015) |
0.1 | 7.5 | GO:0043062 | extracellular structure organization(GO:0043062) |
0.1 | 0.9 | GO:0046606 | negative regulation of centrosome duplication(GO:0010826) negative regulation of centrosome cycle(GO:0046606) |
0.1 | 0.4 | GO:0009115 | xanthine catabolic process(GO:0009115) |
0.1 | 0.5 | GO:2001256 | regulation of store-operated calcium entry(GO:2001256) |
0.1 | 0.2 | GO:1901317 | regulation of sperm motility(GO:1901317) |
0.1 | 0.6 | GO:0021942 | radial glia guided migration of Purkinje cell(GO:0021942) |
0.1 | 0.1 | GO:0042074 | cell migration involved in gastrulation(GO:0042074) |
0.1 | 0.2 | GO:0048808 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.1 | 2.0 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
0.1 | 1.1 | GO:1902572 | regulation of serine-type endopeptidase activity(GO:1900003) negative regulation of serine-type endopeptidase activity(GO:1900004) regulation of serine-type peptidase activity(GO:1902571) negative regulation of serine-type peptidase activity(GO:1902572) |
0.1 | 0.1 | GO:0002739 | regulation of cytokine secretion involved in immune response(GO:0002739) |
0.1 | 2.8 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
0.1 | 2.1 | GO:1901343 | negative regulation of vasculature development(GO:1901343) |
0.1 | 0.4 | GO:0035519 | protein K29-linked ubiquitination(GO:0035519) |
0.1 | 0.1 | GO:0033024 | mast cell homeostasis(GO:0033023) mast cell apoptotic process(GO:0033024) regulation of mast cell apoptotic process(GO:0033025) negative regulation of mast cell apoptotic process(GO:0033026) |
0.1 | 0.1 | GO:0060112 | generation of ovulation cycle rhythm(GO:0060112) |
0.1 | 0.2 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.1 | 0.3 | GO:0080154 | regulation of fertilization(GO:0080154) |
0.1 | 0.3 | GO:0030647 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
0.1 | 0.2 | GO:0035822 | meiotic gene conversion(GO:0006311) gene conversion(GO:0035822) |
0.1 | 0.1 | GO:1901727 | positive regulation of histone deacetylase activity(GO:1901727) |
0.1 | 0.3 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
0.1 | 0.1 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.1 | 0.4 | GO:0030091 | protein repair(GO:0030091) |
0.1 | 0.1 | GO:0002327 | immature B cell differentiation(GO:0002327) |
0.1 | 0.1 | GO:1902913 | auditory receptor cell fate determination(GO:0042668) positive regulation of neuroepithelial cell differentiation(GO:1902913) |
0.1 | 1.0 | GO:0032689 | negative regulation of interferon-gamma production(GO:0032689) |
0.1 | 0.3 | GO:0061469 | regulation of type B pancreatic cell proliferation(GO:0061469) |
0.1 | 0.1 | GO:0001710 | mesodermal cell fate commitment(GO:0001710) |
0.1 | 0.1 | GO:0060279 | positive regulation of ovulation(GO:0060279) |
0.1 | 0.4 | GO:0071236 | cellular response to antibiotic(GO:0071236) |
0.1 | 0.2 | GO:0002317 | plasma cell differentiation(GO:0002317) |
0.1 | 0.2 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
0.1 | 0.3 | GO:2000008 | regulation of protein localization to cell surface(GO:2000008) |
0.1 | 0.1 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
0.1 | 0.1 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.1 | 0.3 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.1 | 0.6 | GO:1901978 | positive regulation of cell cycle checkpoint(GO:1901978) |
0.1 | 0.7 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.1 | 0.3 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
0.1 | 1.0 | GO:0048286 | lung alveolus development(GO:0048286) |
0.1 | 0.1 | GO:1903772 | regulation of viral budding via host ESCRT complex(GO:1903772) |
0.1 | 0.1 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
0.1 | 0.3 | GO:1903817 | negative regulation of delayed rectifier potassium channel activity(GO:1902260) negative regulation of voltage-gated potassium channel activity(GO:1903817) |
0.1 | 0.4 | GO:0045076 | regulation of interleukin-2 biosynthetic process(GO:0045076) |
0.1 | 0.5 | GO:0046321 | positive regulation of fatty acid oxidation(GO:0046321) |
0.1 | 2.0 | GO:0045494 | photoreceptor cell maintenance(GO:0045494) |
0.1 | 0.4 | GO:0035745 | T-helper 2 cell cytokine production(GO:0035745) |
0.1 | 0.1 | GO:1990314 | cellular response to insulin-like growth factor stimulus(GO:1990314) |
0.1 | 0.5 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
0.1 | 0.4 | GO:0030575 | nuclear body organization(GO:0030575) |
0.1 | 0.2 | GO:0045345 | MHC class I biosynthetic process(GO:0045341) regulation of MHC class I biosynthetic process(GO:0045343) positive regulation of MHC class I biosynthetic process(GO:0045345) |
0.1 | 0.2 | GO:0002017 | regulation of blood volume by renal aldosterone(GO:0002017) |
0.1 | 0.2 | GO:0090383 | phagosome acidification(GO:0090383) |
0.1 | 0.1 | GO:0010922 | positive regulation of phosphatase activity(GO:0010922) |
0.1 | 0.1 | GO:0042723 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
0.1 | 0.2 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
0.1 | 0.1 | GO:0098528 | skeletal muscle fiber differentiation(GO:0098528) |
0.1 | 0.1 | GO:0006705 | mineralocorticoid biosynthetic process(GO:0006705) |
0.1 | 0.7 | GO:0016926 | protein desumoylation(GO:0016926) |
0.1 | 0.4 | GO:0036342 | post-anal tail morphogenesis(GO:0036342) |
0.1 | 0.1 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
0.1 | 0.3 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.1 | 0.1 | GO:0032276 | regulation of gonadotropin secretion(GO:0032276) negative regulation of gonadotropin secretion(GO:0032277) |
0.1 | 0.5 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.1 | 1.9 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.1 | 0.2 | GO:0019240 | citrulline biosynthetic process(GO:0019240) |
0.1 | 0.8 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.1 | 0.1 | GO:0045628 | regulation of T-helper 2 cell differentiation(GO:0045628) |
0.1 | 1.2 | GO:0071346 | cellular response to interferon-gamma(GO:0071346) |
0.1 | 0.8 | GO:0017144 | drug metabolic process(GO:0017144) |
0.1 | 0.1 | GO:0010387 | COP9 signalosome assembly(GO:0010387) |
0.1 | 0.3 | GO:0035726 | common myeloid progenitor cell proliferation(GO:0035726) |
0.1 | 0.1 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
0.1 | 0.1 | GO:0061377 | mammary gland alveolus development(GO:0060749) mammary gland lobule development(GO:0061377) |
0.1 | 0.1 | GO:0019042 | viral latency(GO:0019042) |
0.1 | 0.1 | GO:0044854 | plasma membrane raft assembly(GO:0044854) plasma membrane raft organization(GO:0044857) |
0.1 | 0.1 | GO:2000319 | regulation of T-helper 17 cell differentiation(GO:2000319) |
0.1 | 0.6 | GO:0007602 | phototransduction(GO:0007602) |
0.1 | 0.1 | GO:0034505 | tooth mineralization(GO:0034505) |
0.1 | 0.1 | GO:0002118 | aggressive behavior(GO:0002118) |
0.1 | 0.4 | GO:0017121 | phospholipid scrambling(GO:0017121) |
0.1 | 0.3 | GO:0050832 | defense response to fungus(GO:0050832) |
0.1 | 0.5 | GO:0060219 | camera-type eye photoreceptor cell differentiation(GO:0060219) |
0.1 | 0.7 | GO:0048255 | mRNA stabilization(GO:0048255) |
0.1 | 0.2 | GO:0042447 | hormone catabolic process(GO:0042447) |
0.1 | 2.6 | GO:0050909 | sensory perception of taste(GO:0050909) |
0.1 | 5.5 | GO:0019236 | response to pheromone(GO:0019236) |
0.1 | 0.1 | GO:0051001 | negative regulation of nitric-oxide synthase activity(GO:0051001) |
0.1 | 0.2 | GO:0043046 | DNA methylation involved in gamete generation(GO:0043046) |
0.0 | 0.1 | GO:0060742 | epithelial cell differentiation involved in prostate gland development(GO:0060742) |
0.0 | 0.7 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.0 | 0.1 | GO:0002689 | negative regulation of leukocyte chemotaxis(GO:0002689) |
0.0 | 0.3 | GO:0016446 | somatic hypermutation of immunoglobulin genes(GO:0016446) |
0.0 | 0.5 | GO:0007141 | male meiosis I(GO:0007141) |
0.0 | 0.1 | GO:0060005 | vestibular reflex(GO:0060005) |
0.0 | 0.1 | GO:1902267 | polyamine transmembrane transport(GO:1902047) regulation of polyamine transmembrane transport(GO:1902267) |
0.0 | 0.6 | GO:0034260 | negative regulation of GTPase activity(GO:0034260) |
0.0 | 0.0 | GO:0006407 | rRNA export from nucleus(GO:0006407) |
0.0 | 0.4 | GO:0010800 | positive regulation of peptidyl-threonine phosphorylation(GO:0010800) |
0.0 | 0.1 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
0.0 | 0.6 | GO:0060389 | pathway-restricted SMAD protein phosphorylation(GO:0060389) |
0.0 | 0.0 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
0.0 | 0.0 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.0 | 0.5 | GO:0051984 | positive regulation of chromosome segregation(GO:0051984) |
0.0 | 0.1 | GO:0007262 | STAT protein import into nucleus(GO:0007262) |
0.0 | 0.1 | GO:0071286 | cellular response to magnesium ion(GO:0071286) |
0.0 | 0.1 | GO:0072386 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.0 | 0.1 | GO:0070537 | histone H2A K63-linked deubiquitination(GO:0070537) |
0.0 | 0.1 | GO:0014827 | intestine smooth muscle contraction(GO:0014827) |
0.0 | 0.2 | GO:0032096 | negative regulation of response to food(GO:0032096) |
0.0 | 0.0 | GO:0060054 | positive regulation of epithelial cell proliferation involved in wound healing(GO:0060054) |
0.0 | 0.1 | GO:0015747 | urate transport(GO:0015747) |
0.0 | 0.2 | GO:0002021 | response to dietary excess(GO:0002021) |
0.0 | 0.1 | GO:0000270 | peptidoglycan metabolic process(GO:0000270) peptidoglycan catabolic process(GO:0009253) |
0.0 | 0.0 | GO:0006069 | ethanol metabolic process(GO:0006067) ethanol oxidation(GO:0006069) |
0.0 | 0.1 | GO:0090399 | replicative senescence(GO:0090399) |
0.0 | 0.0 | GO:0009597 | detection of virus(GO:0009597) |
0.0 | 0.1 | GO:0090177 | establishment of planar polarity involved in neural tube closure(GO:0090177) |
0.0 | 0.6 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
0.0 | 0.1 | GO:0045686 | negative regulation of glial cell differentiation(GO:0045686) |
0.0 | 0.0 | GO:0070423 | nucleotide-binding oligomerization domain containing signaling pathway(GO:0070423) nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070431) |
0.0 | 0.1 | GO:0046078 | dUMP metabolic process(GO:0046078) |
0.0 | 0.7 | GO:0046426 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
0.0 | 0.0 | GO:0048936 | peripheral nervous system neuron axonogenesis(GO:0048936) |
0.0 | 0.1 | GO:0033504 | floor plate development(GO:0033504) |
0.0 | 0.3 | GO:0010811 | positive regulation of cell-substrate adhesion(GO:0010811) |
0.0 | 1.7 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
0.0 | 0.1 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.0 | 0.5 | GO:0014066 | regulation of phosphatidylinositol 3-kinase signaling(GO:0014066) |
0.0 | 0.0 | GO:0035622 | intrahepatic bile duct development(GO:0035622) |
0.0 | 0.2 | GO:0046415 | urate metabolic process(GO:0046415) |
0.0 | 0.4 | GO:0006706 | steroid catabolic process(GO:0006706) |
0.0 | 0.2 | GO:0042403 | thyroid hormone metabolic process(GO:0042403) |
0.0 | 0.2 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.0 | 0.1 | GO:0071168 | protein localization to chromatin(GO:0071168) |
0.0 | 0.6 | GO:0003333 | amino acid transmembrane transport(GO:0003333) |
0.0 | 0.2 | GO:0006555 | methionine metabolic process(GO:0006555) |
0.0 | 0.1 | GO:1903504 | regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) regulation of mitotic spindle checkpoint(GO:1903504) |
0.0 | 0.4 | GO:0034446 | substrate adhesion-dependent cell spreading(GO:0034446) |
0.0 | 0.1 | GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
0.0 | 0.1 | GO:1903861 | regulation of dendrite extension(GO:1903859) positive regulation of dendrite extension(GO:1903861) |
0.0 | 0.0 | GO:0034436 | glycoprotein transport(GO:0034436) |
0.0 | 0.3 | GO:0015727 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
0.0 | 0.7 | GO:0033141 | positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) |
0.0 | 0.2 | GO:0001779 | natural killer cell differentiation(GO:0001779) |
0.0 | 0.1 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
0.0 | 0.2 | GO:0042159 | lipoprotein catabolic process(GO:0042159) |
0.0 | 0.1 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
0.0 | 0.1 | GO:0010954 | positive regulation of protein processing(GO:0010954) |
0.0 | 0.1 | GO:0007288 | sperm axoneme assembly(GO:0007288) |
0.0 | 0.0 | GO:0043312 | neutrophil degranulation(GO:0043312) |
0.0 | 0.0 | GO:1905153 | regulation of membrane invagination(GO:1905153) |
0.0 | 0.0 | GO:0060142 | regulation of syncytium formation by plasma membrane fusion(GO:0060142) |
0.0 | 0.0 | GO:0060022 | hard palate development(GO:0060022) |
0.0 | 0.1 | GO:0006047 | UDP-N-acetylglucosamine metabolic process(GO:0006047) |
0.0 | 0.0 | GO:0061309 | cardiac neural crest cell development involved in outflow tract morphogenesis(GO:0061309) |
0.0 | 0.0 | GO:1990928 | response to amino acid starvation(GO:1990928) |
0.0 | 0.0 | GO:0001773 | myeloid dendritic cell activation(GO:0001773) |
0.0 | 0.2 | GO:0006301 | postreplication repair(GO:0006301) |
0.0 | 0.0 | GO:0039532 | negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway(GO:0039532) |
0.0 | 0.2 | GO:0032755 | positive regulation of interleukin-6 production(GO:0032755) |
0.0 | 0.0 | GO:0044849 | estrous cycle(GO:0044849) |
0.0 | 0.0 | GO:1903975 | regulation of glial cell migration(GO:1903975) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.4 | 35.5 | GO:0005861 | troponin complex(GO:0005861) |
3.1 | 9.2 | GO:0043259 | laminin-10 complex(GO:0043259) |
2.7 | 5.4 | GO:0034679 | integrin alpha9-beta1 complex(GO:0034679) |
2.7 | 21.5 | GO:0030056 | hemidesmosome(GO:0030056) |
2.5 | 10.0 | GO:0071953 | elastic fiber(GO:0071953) |
2.4 | 14.5 | GO:0098651 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
2.3 | 9.2 | GO:0071141 | SMAD protein complex(GO:0071141) |
2.2 | 6.7 | GO:1990597 | AIP1-IRE1 complex(GO:1990597) |
2.0 | 4.0 | GO:0005610 | laminin-5 complex(GO:0005610) |
2.0 | 5.9 | GO:0005588 | collagen type V trimer(GO:0005588) |
1.9 | 34.3 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
1.8 | 5.5 | GO:0097512 | cardiac myofibril(GO:0097512) |
1.7 | 10.2 | GO:0005915 | zonula adherens(GO:0005915) |
1.6 | 4.8 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
1.6 | 6.3 | GO:1990357 | terminal web(GO:1990357) |
1.5 | 13.7 | GO:0005583 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
1.4 | 11.5 | GO:0045179 | apical cortex(GO:0045179) |
1.4 | 5.4 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
1.3 | 13.3 | GO:0001527 | microfibril(GO:0001527) |
1.3 | 3.8 | GO:0070552 | BRISC complex(GO:0070552) |
1.3 | 3.8 | GO:0097513 | myosin II filament(GO:0097513) |
1.3 | 10.1 | GO:0005859 | muscle myosin complex(GO:0005859) |
1.3 | 18.9 | GO:0005865 | striated muscle thin filament(GO:0005865) |
1.2 | 20.6 | GO:0005614 | interstitial matrix(GO:0005614) |
1.2 | 6.0 | GO:0016460 | myosin II complex(GO:0016460) |
1.2 | 3.6 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
1.2 | 56.8 | GO:0097517 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
1.1 | 4.4 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
1.1 | 3.3 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
1.1 | 3.2 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
1.0 | 1.0 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
1.0 | 9.9 | GO:0005916 | fascia adherens(GO:0005916) |
1.0 | 3.0 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
1.0 | 6.7 | GO:0045180 | basal cortex(GO:0045180) |
1.0 | 10.5 | GO:0035102 | PRC1 complex(GO:0035102) |
0.9 | 7.5 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.9 | 2.7 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
0.9 | 2.7 | GO:0044352 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.9 | 7.2 | GO:0001520 | outer dense fiber(GO:0001520) |
0.9 | 30.5 | GO:0030315 | T-tubule(GO:0030315) |
0.9 | 0.9 | GO:0097149 | centralspindlin complex(GO:0097149) |
0.9 | 3.6 | GO:0030478 | actin cap(GO:0030478) |
0.9 | 8.0 | GO:0097542 | ciliary tip(GO:0097542) |
0.9 | 4.4 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.9 | 1.8 | GO:0032432 | actin filament bundle(GO:0032432) |
0.9 | 3.5 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.9 | 3.5 | GO:0070545 | PeBoW complex(GO:0070545) |
0.9 | 10.4 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.8 | 0.8 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
0.8 | 5.9 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.8 | 23.2 | GO:0031672 | A band(GO:0031672) |
0.8 | 4.1 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
0.8 | 2.4 | GO:1990635 | proximal dendrite(GO:1990635) |
0.8 | 4.0 | GO:0005638 | lamin filament(GO:0005638) |
0.7 | 8.1 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.7 | 45.3 | GO:0005581 | collagen trimer(GO:0005581) |
0.7 | 2.2 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.7 | 1.4 | GO:0016939 | kinesin II complex(GO:0016939) |
0.7 | 7.2 | GO:0031932 | TORC2 complex(GO:0031932) |
0.7 | 3.6 | GO:0032982 | myosin filament(GO:0032982) |
0.7 | 2.1 | GO:1990393 | 3M complex(GO:1990393) |
0.7 | 2.8 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
0.7 | 6.1 | GO:0097470 | ribbon synapse(GO:0097470) |
0.7 | 4.6 | GO:0042382 | paraspeckles(GO:0042382) |
0.6 | 6.5 | GO:0034706 | sodium channel complex(GO:0034706) |
0.6 | 67.8 | GO:0030016 | myofibril(GO:0030016) |
0.6 | 2.5 | GO:0044294 | dendritic growth cone(GO:0044294) |
0.6 | 2.4 | GO:0031143 | pseudopodium(GO:0031143) |
0.6 | 8.3 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
0.6 | 1.8 | GO:0036449 | microtubule minus-end(GO:0036449) |
0.6 | 4.1 | GO:0042587 | glycogen granule(GO:0042587) |
0.6 | 2.9 | GO:0002081 | outer acrosomal membrane(GO:0002081) |
0.6 | 5.8 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
0.6 | 4.1 | GO:0016600 | flotillin complex(GO:0016600) |
0.6 | 5.7 | GO:0031528 | microvillus membrane(GO:0031528) |
0.6 | 0.6 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
0.5 | 7.6 | GO:0043196 | varicosity(GO:0043196) |
0.5 | 3.2 | GO:0090543 | Flemming body(GO:0090543) |
0.5 | 1.6 | GO:0048179 | activin receptor complex(GO:0048179) |
0.5 | 1.6 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.5 | 7.9 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.5 | 1.5 | GO:1990423 | RZZ complex(GO:1990423) |
0.5 | 147.7 | GO:0031012 | extracellular matrix(GO:0031012) |
0.5 | 0.5 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
0.5 | 5.5 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.5 | 4.5 | GO:0033270 | paranode region of axon(GO:0033270) |
0.5 | 1.0 | GO:1990696 | USH2 complex(GO:1990696) |
0.5 | 5.3 | GO:0002102 | podosome(GO:0002102) |
0.5 | 2.4 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.5 | 0.5 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.5 | 1.4 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
0.5 | 17.0 | GO:0016528 | sarcoplasm(GO:0016528) |
0.5 | 1.9 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.5 | 0.9 | GO:0043219 | lateral loop(GO:0043219) |
0.5 | 2.7 | GO:0042629 | mast cell granule(GO:0042629) |
0.4 | 1.8 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.4 | 5.8 | GO:0036038 | MKS complex(GO:0036038) |
0.4 | 3.9 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.4 | 1.7 | GO:0005827 | polar microtubule(GO:0005827) |
0.4 | 1.2 | GO:0070688 | MLL5-L complex(GO:0070688) |
0.4 | 0.8 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
0.4 | 1.2 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
0.4 | 1.6 | GO:0035339 | SPOTS complex(GO:0035339) |
0.4 | 102.1 | GO:0005925 | focal adhesion(GO:0005925) |
0.4 | 1.2 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
0.4 | 7.5 | GO:0005922 | connexon complex(GO:0005922) |
0.4 | 6.6 | GO:0000242 | pericentriolar material(GO:0000242) |
0.4 | 3.5 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.4 | 0.4 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
0.4 | 0.4 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
0.4 | 0.8 | GO:0033010 | paranodal junction(GO:0033010) |
0.4 | 1.5 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.4 | 1.9 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
0.4 | 2.3 | GO:0031209 | SCAR complex(GO:0031209) |
0.4 | 3.4 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.4 | 1.9 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.4 | 1.9 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
0.4 | 1.1 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.4 | 1.8 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.4 | 13.5 | GO:0045095 | keratin filament(GO:0045095) |
0.4 | 1.1 | GO:0035061 | interchromatin granule(GO:0035061) |
0.4 | 117.5 | GO:0005667 | transcription factor complex(GO:0005667) |
0.4 | 0.4 | GO:0000125 | PCAF complex(GO:0000125) |
0.4 | 0.7 | GO:0036195 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.3 | 2.8 | GO:0036157 | outer dynein arm(GO:0036157) |
0.3 | 2.1 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.3 | 0.7 | GO:0044299 | C-fiber(GO:0044299) |
0.3 | 0.3 | GO:0000322 | storage vacuole(GO:0000322) |
0.3 | 30.3 | GO:0043296 | apical junction complex(GO:0043296) |
0.3 | 3.8 | GO:0032426 | stereocilium tip(GO:0032426) |
0.3 | 0.3 | GO:0097651 | phosphatidylinositol 3-kinase complex, class I(GO:0097651) |
0.3 | 4.5 | GO:0060170 | ciliary membrane(GO:0060170) |
0.3 | 3.5 | GO:0034361 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
0.3 | 1.9 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.3 | 2.8 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.3 | 2.5 | GO:0097208 | alveolar lamellar body(GO:0097208) |
0.3 | 0.9 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.3 | 0.9 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.3 | 1.5 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.3 | 2.4 | GO:0042581 | specific granule(GO:0042581) |
0.3 | 2.7 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.3 | 1.5 | GO:0034991 | nuclear meiotic cohesin complex(GO:0034991) |
0.3 | 0.9 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.3 | 0.9 | GO:0045251 | mitochondrial electron transfer flavoprotein complex(GO:0017133) electron transfer flavoprotein complex(GO:0045251) |
0.3 | 7.1 | GO:0016235 | aggresome(GO:0016235) |
0.3 | 0.8 | GO:0045298 | tubulin complex(GO:0045298) |
0.3 | 14.9 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.3 | 1.3 | GO:0030870 | Mre11 complex(GO:0030870) |
0.3 | 0.8 | GO:0044194 | cytolytic granule(GO:0044194) |
0.3 | 2.9 | GO:0035371 | microtubule plus-end(GO:0035371) |
0.3 | 0.8 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
0.3 | 10.4 | GO:0005844 | polysome(GO:0005844) |
0.3 | 5.1 | GO:0048770 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.3 | 1.3 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.3 | 0.5 | GO:0030055 | cell-substrate junction(GO:0030055) |
0.3 | 0.8 | GO:0005726 | perichromatin fibrils(GO:0005726) |
0.2 | 11.2 | GO:0031526 | brush border membrane(GO:0031526) |
0.2 | 0.5 | GO:1990923 | PET complex(GO:1990923) |
0.2 | 0.5 | GO:0031467 | Cul7-RING ubiquitin ligase complex(GO:0031467) |
0.2 | 4.2 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.2 | 6.1 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.2 | 1.4 | GO:0070938 | contractile ring(GO:0070938) |
0.2 | 10.4 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.2 | 3.1 | GO:0097225 | sperm midpiece(GO:0097225) |
0.2 | 1.3 | GO:0097342 | ripoptosome(GO:0097342) |
0.2 | 2.6 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.2 | 0.2 | GO:0000798 | nuclear cohesin complex(GO:0000798) |
0.2 | 7.1 | GO:0042383 | sarcolemma(GO:0042383) |
0.2 | 6.7 | GO:0005903 | brush border(GO:0005903) |
0.2 | 0.4 | GO:0098536 | deuterosome(GO:0098536) |
0.2 | 2.3 | GO:0008305 | integrin complex(GO:0008305) |
0.2 | 0.8 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.2 | 0.4 | GO:0044216 | other organism(GO:0044215) other organism cell(GO:0044216) other organism part(GO:0044217) |
0.2 | 1.0 | GO:0071556 | integral component of cytoplasmic side of endoplasmic reticulum membrane(GO:0071458) integral component of lumenal side of endoplasmic reticulum membrane(GO:0071556) lumenal side of endoplasmic reticulum membrane(GO:0098553) |
0.2 | 1.8 | GO:0036128 | CatSper complex(GO:0036128) |
0.2 | 1.8 | GO:0005858 | axonemal dynein complex(GO:0005858) inner dynein arm(GO:0036156) |
0.2 | 0.8 | GO:0001652 | granular component(GO:0001652) |
0.2 | 0.6 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.2 | 1.8 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.2 | 0.4 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
0.2 | 0.2 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
0.2 | 1.1 | GO:0033391 | chromatoid body(GO:0033391) |
0.2 | 0.6 | GO:0061574 | ASAP complex(GO:0061574) |
0.2 | 0.2 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.2 | 1.5 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.2 | 0.9 | GO:0071547 | piP-body(GO:0071547) |
0.2 | 0.2 | GO:0098576 | lumenal side of membrane(GO:0098576) |
0.2 | 0.7 | GO:0071546 | pi-body(GO:0071546) |
0.2 | 0.5 | GO:0031983 | vesicle lumen(GO:0031983) |
0.2 | 9.8 | GO:0005882 | intermediate filament(GO:0005882) |
0.2 | 0.5 | GO:0071565 | nBAF complex(GO:0071565) |
0.2 | 0.5 | GO:0043293 | apoptosome(GO:0043293) |
0.2 | 3.3 | GO:0000791 | euchromatin(GO:0000791) |
0.2 | 0.5 | GO:0098636 | protein complex involved in cell adhesion(GO:0098636) |
0.2 | 2.5 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.2 | 4.1 | GO:0031901 | early endosome membrane(GO:0031901) |
0.2 | 7.1 | GO:0001533 | cornified envelope(GO:0001533) |
0.1 | 2.2 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
0.1 | 0.6 | GO:0097209 | epidermal lamellar body(GO:0097209) |
0.1 | 1.5 | GO:0018995 | host(GO:0018995) host cell part(GO:0033643) host cell(GO:0043657) |
0.1 | 0.5 | GO:1990716 | axonemal central apparatus(GO:1990716) |
0.1 | 0.4 | GO:0036454 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
0.1 | 3.2 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.1 | 0.4 | GO:0042824 | MHC class I peptide loading complex(GO:0042824) TAP complex(GO:0042825) |
0.1 | 0.3 | GO:0097452 | GAIT complex(GO:0097452) |
0.1 | 0.4 | GO:0001651 | dense fibrillar component(GO:0001651) |
0.1 | 0.6 | GO:0070187 | telosome(GO:0070187) |
0.1 | 1.2 | GO:0016514 | SWI/SNF complex(GO:0016514) |
0.1 | 0.4 | GO:0009279 | cell outer membrane(GO:0009279) cell envelope(GO:0030313) external encapsulating structure part(GO:0044462) |
0.1 | 0.7 | GO:0070578 | RISC-loading complex(GO:0070578) |
0.1 | 1.7 | GO:0001673 | male germ cell nucleus(GO:0001673) |
0.1 | 3.9 | GO:0005901 | caveola(GO:0005901) |
0.1 | 0.6 | GO:0043083 | synaptic cleft(GO:0043083) |
0.1 | 0.5 | GO:0089701 | U2AF(GO:0089701) |
0.1 | 0.2 | GO:0097443 | sorting endosome(GO:0097443) |
0.1 | 0.6 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
0.1 | 0.5 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
0.1 | 8.8 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.1 | 0.3 | GO:0090533 | sodium:potassium-exchanging ATPase complex(GO:0005890) cation-transporting ATPase complex(GO:0090533) |
0.1 | 0.3 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.1 | 0.6 | GO:0071439 | clathrin complex(GO:0071439) |
0.1 | 0.1 | GO:0000178 | exosome (RNase complex)(GO:0000178) |
0.1 | 0.4 | GO:0005796 | Golgi lumen(GO:0005796) |
0.1 | 38.7 | GO:0009986 | cell surface(GO:0009986) |
0.1 | 0.6 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
0.1 | 1.0 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.1 | 1.9 | GO:0016592 | mediator complex(GO:0016592) |
0.1 | 0.2 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.1 | 0.2 | GO:0044214 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
0.1 | 0.1 | GO:0070160 | occluding junction(GO:0070160) |
0.1 | 0.2 | GO:0043159 | acrosomal matrix(GO:0043159) |
0.1 | 0.3 | GO:0002177 | manchette(GO:0002177) |
0.1 | 0.1 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
0.1 | 6.6 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.1 | 0.3 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
0.1 | 0.2 | GO:1990726 | Lsm1-7-Pat1 complex(GO:1990726) |
0.1 | 0.3 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.1 | 0.6 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.1 | 3.7 | GO:0001669 | acrosomal vesicle(GO:0001669) |
0.0 | 0.2 | GO:0072557 | IPAF inflammasome complex(GO:0072557) |
0.0 | 0.2 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
0.0 | 0.1 | GO:0031501 | mannosyltransferase complex(GO:0031501) |
0.0 | 0.1 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.0 | 0.3 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.0 | 0.3 | GO:0044453 | nuclear membrane part(GO:0044453) |
0.0 | 0.0 | GO:0070522 | ERCC4-ERCC1 complex(GO:0070522) |
0.0 | 0.2 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
0.0 | 0.0 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
0.0 | 0.1 | GO:1990745 | EARP complex(GO:1990745) |
0.0 | 0.1 | GO:0031083 | BLOC-1 complex(GO:0031083) |
0.0 | 0.0 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.4 | 16.3 | GO:0030172 | troponin C binding(GO:0030172) |
4.9 | 14.8 | GO:1902282 | voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1902282) |
3.8 | 30.1 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
3.7 | 11.2 | GO:0035939 | microsatellite binding(GO:0035939) |
3.6 | 43.0 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
3.4 | 24.0 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
3.3 | 6.7 | GO:0070888 | E-box binding(GO:0070888) |
3.1 | 9.4 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
2.9 | 8.8 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
2.8 | 8.3 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
2.7 | 8.0 | GO:0031014 | troponin T binding(GO:0031014) |
2.6 | 15.5 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
2.5 | 7.5 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) |
2.4 | 9.6 | GO:0038064 | collagen receptor activity(GO:0038064) |
2.4 | 7.2 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
2.3 | 11.5 | GO:0004111 | creatine kinase activity(GO:0004111) |
2.3 | 2.3 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
2.1 | 6.4 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
2.1 | 8.2 | GO:0098821 | BMP receptor activity(GO:0098821) |
2.0 | 16.1 | GO:0017166 | vinculin binding(GO:0017166) |
2.0 | 2.0 | GO:0005523 | tropomyosin binding(GO:0005523) |
2.0 | 8.0 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
2.0 | 5.9 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
1.9 | 13.6 | GO:0031432 | titin binding(GO:0031432) |
1.9 | 30.6 | GO:0008307 | structural constituent of muscle(GO:0008307) |
1.8 | 9.2 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
1.8 | 7.3 | GO:0001224 | RNA polymerase II transcription cofactor binding(GO:0001224) |
1.8 | 1.8 | GO:0048030 | disaccharide binding(GO:0048030) |
1.8 | 5.3 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
1.7 | 9.9 | GO:0038132 | neuregulin binding(GO:0038132) |
1.6 | 6.6 | GO:0022833 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
1.6 | 8.0 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
1.6 | 9.3 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
1.5 | 4.6 | GO:0031826 | type 2A serotonin receptor binding(GO:0031826) |
1.5 | 4.6 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
1.5 | 16.4 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
1.5 | 4.4 | GO:0019770 | IgG receptor activity(GO:0019770) |
1.5 | 4.4 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
1.4 | 8.7 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
1.4 | 7.2 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
1.4 | 5.7 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
1.4 | 2.8 | GO:0098748 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
1.4 | 4.1 | GO:0071553 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
1.4 | 12.3 | GO:0038191 | neuropilin binding(GO:0038191) |
1.3 | 4.0 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
1.3 | 6.4 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
1.3 | 3.8 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
1.3 | 3.8 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
1.2 | 3.7 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
1.2 | 8.7 | GO:0048185 | activin binding(GO:0048185) |
1.2 | 1.2 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
1.2 | 13.4 | GO:0031005 | filamin binding(GO:0031005) |
1.2 | 3.6 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
1.2 | 21.6 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
1.2 | 7.1 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
1.2 | 12.8 | GO:0070700 | BMP receptor binding(GO:0070700) |
1.2 | 3.5 | GO:0008107 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
1.1 | 29.4 | GO:0043236 | laminin binding(GO:0043236) |
1.1 | 3.4 | GO:0008732 | threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
1.1 | 10.1 | GO:0004445 | inositol-polyphosphate 5-phosphatase activity(GO:0004445) |
1.1 | 3.3 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) DNA (cytosine-5-)-methyltransferase activity, acting on CpG substrates(GO:0051718) |
1.1 | 5.6 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
1.1 | 20.9 | GO:0003785 | actin monomer binding(GO:0003785) |
1.1 | 5.4 | GO:0051525 | NFAT protein binding(GO:0051525) |
1.1 | 3.2 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
1.1 | 3.2 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
1.0 | 8.4 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
1.0 | 6.3 | GO:0071837 | HMG box domain binding(GO:0071837) |
1.0 | 3.1 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
1.0 | 5.1 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
1.0 | 2.0 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
1.0 | 3.1 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
1.0 | 3.0 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
1.0 | 3.0 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
1.0 | 3.0 | GO:0038181 | bile acid receptor activity(GO:0038181) |
1.0 | 2.9 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
1.0 | 4.8 | GO:0000099 | sulfur amino acid transmembrane transporter activity(GO:0000099) |
1.0 | 2.9 | GO:0051870 | methotrexate binding(GO:0051870) |
0.9 | 6.6 | GO:0018631 | 3-(3-hydroxyphenyl)propionate hydroxylase activity(GO:0008688) 4-chlorobenzaldehyde oxidase activity(GO:0018471) 3,5-xylenol methylhydroxylase activity(GO:0018630) phenylacetate hydroxylase activity(GO:0018631) 4-nitrophenol 4-monooxygenase activity(GO:0018632) dimethyl sulfide monooxygenase activity(GO:0018633) alpha-pinene monooxygenase [NADH] activity(GO:0018634) 1-hydroxy-2-naphthoate hydroxylase activity(GO:0018637) toluene 4-monooxygenase activity(GO:0018638) xylene monooxygenase activity(GO:0018639) dibenzothiophene monooxygenase activity(GO:0018640) 6-hydroxy-3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018641) chlorophenol 4-monooxygenase activity(GO:0018642) carbon disulfide oxygenase activity(GO:0018643) toluene 2-monooxygenase activity(GO:0018644) 1-hydroxy-2-oxolimonene 1,2-monooxygenase activity(GO:0018646) phenanthrene 1,2-monooxygenase activity(GO:0018647) tetrahydrofuran hydroxylase activity(GO:0018649) styrene monooxygenase activity(GO:0018650) toluene-4-sulfonate monooxygenase activity(GO:0018651) toluene-sulfonate methyl-monooxygenase activity(GO:0018652) 3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018653) 2-hydroxy-phenylacetate hydroxylase activity(GO:0018654) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA 1,2-monooxygenase activity(GO:0018655) phenanthrene 3,4-monooxygenase activity(GO:0018656) toluene 3-monooxygenase activity(GO:0018657) 4-hydroxyphenylacetate,NADH:oxygen oxidoreductase (3-hydroxylating) activity(GO:0018660) limonene monooxygenase activity(GO:0019113) 2-methylnaphthalene hydroxylase activity(GO:0034526) 1-methylnaphthalene hydroxylase activity(GO:0034534) bisphenol A hydroxylase A activity(GO:0034560) salicylate 5-hydroxylase activity(GO:0034785) isobutylamine N-hydroxylase activity(GO:0034791) branched-chain dodecylbenzene sulfonate monooxygenase activity(GO:0034802) 3-HSA hydroxylase activity(GO:0034819) 4-hydroxypyridine-3-hydroxylase activity(GO:0034894) 2-octaprenyl-3-methyl-6-methoxy-1,4-benzoquinol hydroxylase activity(GO:0043719) 6-hydroxynicotinate 3-monooxygenase activity(GO:0043731) thalianol hydroxylase activity(GO:0080014) |
0.9 | 10.4 | GO:0044548 | S100 protein binding(GO:0044548) |
0.9 | 2.8 | GO:0019959 | interleukin-8 binding(GO:0019959) |
0.9 | 4.6 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
0.9 | 5.4 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.9 | 1.8 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
0.9 | 9.9 | GO:0001134 | transcription factor activity, transcription factor recruiting(GO:0001134) |
0.9 | 11.6 | GO:0001968 | fibronectin binding(GO:0001968) |
0.9 | 5.3 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
0.9 | 6.2 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.9 | 0.9 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.9 | 0.9 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
0.9 | 8.5 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.8 | 15.3 | GO:0005112 | Notch binding(GO:0005112) |
0.8 | 4.2 | GO:0071253 | connexin binding(GO:0071253) |
0.8 | 2.5 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.8 | 7.3 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
0.8 | 1.6 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.8 | 2.4 | GO:0051733 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) |
0.8 | 4.0 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.8 | 2.4 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
0.8 | 29.6 | GO:0005109 | frizzled binding(GO:0005109) |
0.8 | 2.4 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.8 | 2.3 | GO:0005522 | profilin binding(GO:0005522) |
0.8 | 2.3 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.8 | 3.1 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.8 | 2.3 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.8 | 3.1 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.8 | 1.5 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
0.8 | 2.3 | GO:0000702 | oxidized base lesion DNA N-glycosylase activity(GO:0000702) |
0.7 | 3.0 | GO:1990715 | mRNA CDS binding(GO:1990715) |
0.7 | 3.0 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.7 | 2.2 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
0.7 | 3.6 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.7 | 2.2 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.7 | 13.0 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.7 | 50.7 | GO:0005178 | integrin binding(GO:0005178) |
0.7 | 5.0 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.7 | 7.8 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.7 | 2.8 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.7 | 0.7 | GO:0038085 | vascular endothelial growth factor binding(GO:0038085) |
0.7 | 2.1 | GO:0004174 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
0.7 | 6.9 | GO:0004955 | prostaglandin receptor activity(GO:0004955) |
0.7 | 2.8 | GO:0036374 | gamma-glutamyltransferase activity(GO:0003840) glutathione hydrolase activity(GO:0036374) |
0.7 | 5.5 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.7 | 7.6 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.7 | 8.9 | GO:0015026 | coreceptor activity(GO:0015026) |
0.7 | 2.1 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
0.7 | 4.1 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.7 | 0.7 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.7 | 15.5 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.7 | 5.3 | GO:0015922 | aspartate oxidase activity(GO:0015922) |
0.7 | 2.6 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) |
0.7 | 44.4 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.7 | 4.6 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.6 | 1.9 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) |
0.6 | 1.3 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.6 | 0.6 | GO:0070052 | collagen V binding(GO:0070052) |
0.6 | 1.9 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.6 | 3.8 | GO:0016936 | galactoside binding(GO:0016936) |
0.6 | 1.9 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
0.6 | 14.1 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
0.6 | 12.2 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.6 | 10.4 | GO:0005355 | glucose transmembrane transporter activity(GO:0005355) |
0.6 | 20.7 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.6 | 12.1 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.6 | 1.8 | GO:0055100 | adiponectin binding(GO:0055100) |
0.6 | 1.8 | GO:0050692 | DBD domain binding(GO:0050692) |
0.6 | 4.1 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.6 | 0.6 | GO:0070840 | dynein complex binding(GO:0070840) |
0.6 | 1.7 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.6 | 1.7 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
0.6 | 2.8 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.6 | 46.2 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.6 | 7.3 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
0.6 | 2.8 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.6 | 1.7 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.5 | 8.2 | GO:0045296 | cadherin binding(GO:0045296) |
0.5 | 1.6 | GO:0035651 | AP-3 adaptor complex binding(GO:0035651) |
0.5 | 1.6 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.5 | 0.5 | GO:0035514 | DNA demethylase activity(GO:0035514) |
0.5 | 8.6 | GO:0042805 | actinin binding(GO:0042805) |
0.5 | 2.7 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.5 | 1.6 | GO:0008142 | oxysterol binding(GO:0008142) |
0.5 | 1.6 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.5 | 3.2 | GO:0016421 | CoA carboxylase activity(GO:0016421) |
0.5 | 1.6 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.5 | 1.6 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.5 | 19.8 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.5 | 0.5 | GO:0031013 | troponin I binding(GO:0031013) |
0.5 | 1.5 | GO:0004471 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) |
0.5 | 0.5 | GO:0004954 | prostanoid receptor activity(GO:0004954) |
0.5 | 3.0 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.5 | 1.5 | GO:1990254 | keratin filament binding(GO:1990254) |
0.5 | 3.0 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.5 | 54.0 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
0.5 | 1.0 | GO:0015193 | L-proline transmembrane transporter activity(GO:0015193) |
0.5 | 2.9 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.5 | 1.0 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.5 | 1.4 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.5 | 2.9 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
0.5 | 0.5 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
0.5 | 3.3 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.5 | 1.9 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
0.5 | 4.1 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.5 | 1.8 | GO:0004322 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.5 | 1.8 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.4 | 3.1 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.4 | 43.8 | GO:0008201 | heparin binding(GO:0008201) |
0.4 | 1.3 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.4 | 12.2 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.4 | 3.9 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.4 | 1.3 | GO:0045545 | syndecan binding(GO:0045545) |
0.4 | 0.9 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
0.4 | 4.7 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.4 | 2.6 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.4 | 13.6 | GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding(GO:0000980) |
0.4 | 2.1 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.4 | 1.7 | GO:0004558 | alpha-1,4-glucosidase activity(GO:0004558) |
0.4 | 13.1 | GO:0005518 | collagen binding(GO:0005518) |
0.4 | 0.4 | GO:0017098 | sulfonylurea receptor binding(GO:0017098) |
0.4 | 2.5 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.4 | 0.8 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
0.4 | 1.6 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.4 | 0.8 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.4 | 12.3 | GO:0004714 | transmembrane receptor protein tyrosine kinase activity(GO:0004714) |
0.4 | 0.8 | GO:0070538 | oleic acid binding(GO:0070538) |
0.4 | 3.2 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.4 | 0.4 | GO:0034617 | tetrahydrobiopterin binding(GO:0034617) |
0.4 | 4.8 | GO:0005521 | lamin binding(GO:0005521) |
0.4 | 3.6 | GO:0043121 | neurotrophin binding(GO:0043121) |
0.4 | 11.5 | GO:0008748 | N-ethylmaleimide reductase activity(GO:0008748) reduced coenzyme F420 dehydrogenase activity(GO:0043738) sulfur oxygenase reductase activity(GO:0043826) malolactic enzyme activity(GO:0043883) epoxyqueuosine reductase activity(GO:0052693) |
0.4 | 3.2 | GO:0008932 | lytic endotransglycosylase activity(GO:0008932) |
0.4 | 2.4 | GO:0035381 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.4 | 3.5 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.4 | 1.2 | GO:0016015 | morphogen activity(GO:0016015) |
0.4 | 1.6 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
0.4 | 1.2 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.4 | 109.2 | GO:0003779 | actin binding(GO:0003779) |
0.4 | 0.4 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
0.4 | 1.9 | GO:0015181 | arginine transmembrane transporter activity(GO:0015181) L-lysine transmembrane transporter activity(GO:0015189) |
0.4 | 1.2 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
0.4 | 1.5 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
0.4 | 0.8 | GO:0097603 | temperature-gated ion channel activity(GO:0097603) |
0.4 | 1.9 | GO:0004340 | glucokinase activity(GO:0004340) hexokinase activity(GO:0004396) |
0.4 | 0.8 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.4 | 0.4 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.4 | 1.5 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.4 | 1.5 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
0.4 | 1.5 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.4 | 1.9 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.4 | 3.7 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
0.4 | 1.1 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
0.4 | 1.1 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.4 | 72.8 | GO:0000982 | transcription factor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0000982) |
0.4 | 1.1 | GO:0005534 | galactose binding(GO:0005534) |
0.4 | 1.5 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
0.4 | 0.4 | GO:0051373 | FATZ binding(GO:0051373) |
0.4 | 2.2 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) intronic transcription regulatory region DNA binding(GO:0044213) |
0.4 | 1.4 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.4 | 3.2 | GO:0001846 | opsonin binding(GO:0001846) |
0.4 | 3.6 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.4 | 1.8 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.4 | 0.7 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
0.4 | 1.1 | GO:0015119 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
0.4 | 1.8 | GO:0051022 | Rho GDP-dissociation inhibitor binding(GO:0051022) |
0.3 | 1.0 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
0.3 | 1.0 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
0.3 | 2.7 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.3 | 1.4 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
0.3 | 2.7 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.3 | 2.7 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
0.3 | 1.0 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
0.3 | 3.0 | GO:0015250 | water channel activity(GO:0015250) |
0.3 | 1.3 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.3 | 1.0 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
0.3 | 1.6 | GO:0001601 | peptide YY receptor activity(GO:0001601) |
0.3 | 0.7 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.3 | 26.7 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.3 | 1.0 | GO:0043891 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.3 | 0.6 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.3 | 1.0 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.3 | 1.6 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
0.3 | 1.3 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.3 | 1.3 | GO:0019957 | C-C chemokine binding(GO:0019957) |
0.3 | 0.6 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.3 | 6.9 | GO:0005272 | sodium channel activity(GO:0005272) |
0.3 | 1.2 | GO:0034584 | piRNA binding(GO:0034584) |
0.3 | 1.2 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.3 | 3.1 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
0.3 | 0.9 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.3 | 1.9 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.3 | 8.9 | GO:0030551 | cyclic nucleotide binding(GO:0030551) |
0.3 | 0.9 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
0.3 | 0.6 | GO:0004772 | sterol O-acyltransferase activity(GO:0004772) |
0.3 | 0.6 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
0.3 | 4.2 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.3 | 0.9 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.3 | 0.9 | GO:0003680 | AT DNA binding(GO:0003680) |
0.3 | 3.0 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.3 | 4.7 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
0.3 | 0.9 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
0.3 | 0.3 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.3 | 1.2 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
0.3 | 0.3 | GO:0030375 | thyroid hormone receptor coactivator activity(GO:0030375) |
0.3 | 0.3 | GO:0004096 | catalase activity(GO:0004096) |
0.3 | 0.6 | GO:0004104 | cholinesterase activity(GO:0004104) |
0.3 | 1.1 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
0.3 | 1.4 | GO:0004854 | xanthine dehydrogenase activity(GO:0004854) oxidoreductase activity, acting on CH or CH2 groups, NAD or NADP as acceptor(GO:0016726) |
0.3 | 0.3 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.3 | 3.3 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.3 | 0.6 | GO:0016406 | carnitine O-acyltransferase activity(GO:0016406) |
0.3 | 3.0 | GO:0051400 | BH domain binding(GO:0051400) |
0.3 | 0.8 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.3 | 0.5 | GO:0048019 | receptor antagonist activity(GO:0048019) |
0.3 | 3.3 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.3 | 1.1 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.3 | 1.4 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
0.3 | 2.9 | GO:0046977 | TAP binding(GO:0046977) |
0.3 | 0.3 | GO:0016623 | aldehyde oxidase activity(GO:0004031) oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor(GO:0016623) |
0.3 | 1.6 | GO:0015301 | anion:anion antiporter activity(GO:0015301) |
0.3 | 0.5 | GO:2001070 | starch binding(GO:2001070) |
0.3 | 1.8 | GO:0043995 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
0.3 | 2.1 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.3 | 0.3 | GO:0004676 | 3-phosphoinositide-dependent protein kinase activity(GO:0004676) |
0.3 | 0.3 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
0.3 | 4.9 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.3 | 4.3 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.3 | 0.5 | GO:0035276 | alcohol dehydrogenase activity, zinc-dependent(GO:0004024) ethanol binding(GO:0035276) |
0.3 | 1.5 | GO:0061505 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.2 | 1.0 | GO:0015375 | glycine:sodium symporter activity(GO:0015375) |
0.2 | 1.5 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.2 | 0.7 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.2 | 1.0 | GO:0005329 | dopamine transmembrane transporter activity(GO:0005329) |
0.2 | 1.2 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.2 | 1.0 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.2 | 1.2 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.2 | 1.0 | GO:0008808 | cardiolipin synthase activity(GO:0008808) phosphatidyltransferase activity(GO:0030572) |
0.2 | 1.9 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.2 | 0.9 | GO:0055106 | ligase regulator activity(GO:0055103) ubiquitin-protein transferase regulator activity(GO:0055106) |
0.2 | 0.7 | GO:0033592 | RNA strand annealing activity(GO:0033592) |
0.2 | 0.7 | GO:0030519 | snoRNP binding(GO:0030519) |
0.2 | 1.1 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.2 | 0.9 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.2 | 5.2 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.2 | 1.6 | GO:0016918 | retinal binding(GO:0016918) |
0.2 | 1.3 | GO:0043495 | protein anchor(GO:0043495) |
0.2 | 4.2 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.2 | 2.6 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.2 | 1.3 | GO:0015180 | L-alanine transmembrane transporter activity(GO:0015180) alanine transmembrane transporter activity(GO:0022858) |
0.2 | 0.4 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.2 | 0.2 | GO:0005167 | neurotrophin TRK receptor binding(GO:0005167) |
0.2 | 1.5 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.2 | 0.4 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
0.2 | 0.4 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.2 | 1.6 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
0.2 | 2.5 | GO:0015106 | bicarbonate transmembrane transporter activity(GO:0015106) |
0.2 | 3.9 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.2 | 0.6 | GO:0035877 | death effector domain binding(GO:0035877) |
0.2 | 2.8 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.2 | 1.0 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
0.2 | 0.6 | GO:0030274 | LIM domain binding(GO:0030274) |
0.2 | 2.2 | GO:0005451 | monovalent cation:proton antiporter activity(GO:0005451) |
0.2 | 1.0 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.2 | 1.4 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.2 | 0.2 | GO:0032190 | acrosin binding(GO:0032190) |
0.2 | 5.6 | GO:0008009 | chemokine activity(GO:0008009) |
0.2 | 0.2 | GO:0031705 | bombesin receptor binding(GO:0031705) |
0.2 | 0.6 | GO:0034922 | 2,3-dihydroxy DDT 1,2-dioxygenase activity(GO:0018542) phenanthrene dioxygenase activity(GO:0018555) 2,2',3-trihydroxybiphenyl dioxygenase activity(GO:0018556) 1,2-dihydroxyfluorene 1,1-alpha-dioxygenase activity(GO:0018557) 5,6-dihydroxy-3-methyl-2-oxo-1,2-dihydroquinoline dioxygenase activity(GO:0018558) 1,1-dichloro-2-(dihydroxy-4-chlorophenyl)-(4-chlorophenyl)ethene 1,2-dioxygenase activity(GO:0018559) protocatechuate 3,4-dioxygenase type II activity(GO:0018560) 2'-aminobiphenyl-2,3-diol 1,2-dioxygenase activity(GO:0018561) 3,4-dihydroxyfluorene 4,4-alpha-dioxygenase activity(GO:0018562) 2,3-dihydroxy-ethylbenzene 1,2-dioxygenase activity(GO:0018563) carbazole 1,9a-dioxygenase activity(GO:0018564) dihydroxydibenzothiophene dioxygenase activity(GO:0018565) 1,2-dihydroxynaphthalene-6-sulfonate 1,8a-dioxygenase activity(GO:0018566) styrene dioxygenase activity(GO:0018567) 3,4-dihydroxyphenanthrene dioxygenase activity(GO:0018568) hydroquinone 1,2-dioxygenase activity(GO:0018569) p-cumate 2,3-dioxygenase activity(GO:0018570) 2,3-dihydroxy-p-cumate dioxygenase activity(GO:0018571) 3,5-dichlorocatechol 1,2-dioxygenase activity(GO:0018572) 2-aminophenol 1,6-dioxygenase activity(GO:0018573) 2,6-dichloro-p-hydroquinone 1,2-dioxygenase activity(GO:0018574) chlorocatechol 1,2-dioxygenase activity(GO:0018575) catechol dioxygenase activity(GO:0019114) dihydroxyfluorene dioxygenase activity(GO:0019117) 5-aminosalicylate dioxygenase activity(GO:0034543) 3-hydroxy-2-naphthoate 2,3-dioxygenase activity(GO:0034803) benzo(a)pyrene 11,12-dioxygenase activity(GO:0034806) benzo(a)pyrene 4,5-dioxygenase activity(GO:0034808) 4,5-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034810) benzo(a)pyrene 9,10-dioxygenase activity(GO:0034811) 9,10-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034812) benzo(a)pyrene 7,8-dioxygenase activity(GO:0034813) 7,8-dihydroxy benzo(a)pyrene dioxygenase activity(GO:0034814) 1,2-dihydroxy-5,6,7,8-tetrahydronaphthalene extradiol dioxygenase activity(GO:0034827) 2-mercaptobenzothiazole dioxygenase activity(GO:0034834) pyridine-3,4-diol dioxygenase activity(GO:0034895) pyrene dioxygenase activity(GO:0034920) 4,5-dihydroxypyrene dioxygenase activity(GO:0034922) phenanthrene-4-carboxylate dioxygenase activity(GO:0034934) tetrachlorobenzene dioxygenase activity(GO:0034935) 4,6-dichloro-3-methylcatechol 1,2-dioxygenase activity(GO:0034936) 2,3-dihydroxydiphenyl ether dioxygenase activity(GO:0034955) diphenyl ether 1,2-dioxygenase activity(GO:0034956) arachidonate 8(S)-lipoxygenase activity(GO:0036403) 4-hydroxycatechol 1,2-dioxygenase activity(GO:0047074) |
0.2 | 0.8 | GO:0005113 | patched binding(GO:0005113) |
0.2 | 2.7 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.2 | 0.2 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.2 | 0.6 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.2 | 0.7 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.2 | 0.2 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.2 | 2.6 | GO:0042974 | retinoic acid receptor binding(GO:0042974) |
0.2 | 0.5 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
0.2 | 0.7 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.2 | 6.0 | GO:0019107 | myristoyltransferase activity(GO:0019107) |
0.2 | 1.3 | GO:0008430 | selenium binding(GO:0008430) |
0.2 | 0.4 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
0.2 | 2.2 | GO:0015643 | toxic substance binding(GO:0015643) |
0.2 | 0.5 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.2 | 6.6 | GO:0008013 | beta-catenin binding(GO:0008013) |
0.2 | 0.2 | GO:0016751 | S-succinyltransferase activity(GO:0016751) |
0.2 | 0.2 | GO:0016415 | octanoyltransferase activity(GO:0016415) |
0.2 | 17.5 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.2 | 0.9 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.2 | 5.8 | GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen(GO:0016712) |
0.2 | 0.7 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.2 | 2.0 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.2 | 5.2 | GO:0045182 | translation regulator activity(GO:0045182) |
0.2 | 0.7 | GO:0018741 | alkyl sulfatase activity(GO:0018741) endosulfan hemisulfate sulfatase activity(GO:0034889) endosulfan sulfate hydrolase activity(GO:0034902) |
0.2 | 1.0 | GO:0050700 | CARD domain binding(GO:0050700) |
0.2 | 1.0 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) |
0.2 | 1.2 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.2 | 0.5 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
0.2 | 1.8 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.2 | 4.5 | GO:0033549 | MAP kinase phosphatase activity(GO:0033549) |
0.2 | 1.4 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.2 | 1.4 | GO:0001158 | enhancer sequence-specific DNA binding(GO:0001158) |
0.2 | 2.1 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.2 | 2.5 | GO:0005539 | glycosaminoglycan binding(GO:0005539) |
0.2 | 0.8 | GO:0042285 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.2 | 0.2 | GO:0050051 | leukotriene-B4 20-monooxygenase activity(GO:0050051) |
0.2 | 1.8 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.2 | 3.6 | GO:0005080 | protein kinase C binding(GO:0005080) |
0.2 | 0.9 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
0.2 | 0.5 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
0.1 | 0.1 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.1 | 27.5 | GO:0030695 | GTPase regulator activity(GO:0030695) |
0.1 | 1.5 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.1 | 0.3 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.1 | 0.3 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.1 | 3.2 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.1 | 4.3 | GO:0019838 | growth factor binding(GO:0019838) |
0.1 | 0.4 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.1 | 0.4 | GO:0005499 | vitamin D binding(GO:0005499) |
0.1 | 0.6 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
0.1 | 1.0 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.1 | 0.3 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.1 | 0.4 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.1 | 1.4 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.1 | 5.8 | GO:0004896 | cytokine receptor activity(GO:0004896) |
0.1 | 0.4 | GO:0001222 | transcription corepressor binding(GO:0001222) |
0.1 | 0.1 | GO:0032139 | dinucleotide insertion or deletion binding(GO:0032139) |
0.1 | 1.1 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.1 | 0.7 | GO:0042379 | chemokine receptor binding(GO:0042379) |
0.1 | 0.4 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.1 | 1.1 | GO:0015605 | organophosphate ester transmembrane transporter activity(GO:0015605) |
0.1 | 0.1 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.1 | 1.9 | GO:0008252 | nucleotidase activity(GO:0008252) |
0.1 | 1.9 | GO:0016248 | channel inhibitor activity(GO:0016248) |
0.1 | 0.2 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.1 | 0.5 | GO:0004953 | icosanoid receptor activity(GO:0004953) |
0.1 | 1.9 | GO:0030332 | cyclin binding(GO:0030332) |
0.1 | 0.3 | GO:0004052 | arachidonate 12-lipoxygenase activity(GO:0004052) |
0.1 | 0.3 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
0.1 | 2.6 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.1 | 0.1 | GO:0001012 | RNA polymerase II regulatory region DNA binding(GO:0001012) |
0.1 | 0.4 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
0.1 | 0.2 | GO:0004103 | choline kinase activity(GO:0004103) |
0.1 | 2.1 | GO:0050699 | WW domain binding(GO:0050699) |
0.1 | 0.3 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.1 | 0.9 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
0.1 | 0.1 | GO:0070815 | peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
0.1 | 0.2 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.1 | 0.3 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) |
0.1 | 0.1 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
0.1 | 0.2 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
0.1 | 0.6 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
0.1 | 0.9 | GO:0003796 | lysozyme activity(GO:0003796) |
0.1 | 1.7 | GO:0004889 | acetylcholine-activated cation-selective channel activity(GO:0004889) |
0.1 | 13.3 | GO:0005125 | cytokine activity(GO:0005125) |
0.1 | 0.3 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.1 | 1.1 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.1 | 1.3 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
0.1 | 1.6 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.1 | 0.2 | GO:0030284 | estrogen receptor activity(GO:0030284) |
0.1 | 0.4 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.1 | 0.8 | GO:0071949 | FAD binding(GO:0071949) |
0.1 | 0.5 | GO:0048038 | quinone binding(GO:0048038) |
0.1 | 0.8 | GO:0016920 | pyroglutamyl-peptidase activity(GO:0016920) |
0.1 | 0.6 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.1 | 0.5 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
0.1 | 0.3 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.1 | 2.1 | GO:0008392 | arachidonic acid epoxygenase activity(GO:0008392) |
0.1 | 1.4 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.1 | 0.4 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.1 | 0.4 | GO:0001228 | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001228) |
0.1 | 4.8 | GO:0003777 | microtubule motor activity(GO:0003777) |
0.1 | 1.8 | GO:0017046 | peptide hormone binding(GO:0017046) |
0.1 | 3.1 | GO:0004860 | protein kinase inhibitor activity(GO:0004860) |
0.1 | 0.5 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.1 | 0.9 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
0.1 | 1.3 | GO:0030331 | estrogen receptor binding(GO:0030331) |
0.1 | 0.1 | GO:0044020 | histone methyltransferase activity (H4-R3 specific)(GO:0044020) |
0.1 | 0.3 | GO:0102345 | 3-hydroxy-behenoyl-CoA dehydratase activity(GO:0102344) 3-hydroxy-lignoceroyl-CoA dehydratase activity(GO:0102345) |
0.1 | 0.1 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
0.1 | 0.4 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.1 | 0.2 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
0.1 | 0.2 | GO:0030943 | mitochondrion targeting sequence binding(GO:0030943) |
0.1 | 0.2 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
0.1 | 28.2 | GO:0043565 | sequence-specific DNA binding(GO:0043565) |
0.1 | 0.2 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
0.1 | 1.1 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.1 | 0.6 | GO:0010435 | acyl-CoA ligase activity(GO:0003996) 3-oxo-2-(2'-pentenyl)cyclopentane-1-octanoic acid CoA ligase activity(GO:0010435) 3-isopropenyl-6-oxoheptanoyl-CoA synthetase activity(GO:0018854) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA synthetase activity(GO:0018855) benzoyl acetate-CoA ligase activity(GO:0018856) 2,4-dichlorobenzoate-CoA ligase activity(GO:0018857) pivalate-CoA ligase activity(GO:0034783) cyclopropanecarboxylate-CoA ligase activity(GO:0034793) adipate-CoA ligase activity(GO:0034796) citronellyl-CoA ligase activity(GO:0034823) mentha-1,3-dione-CoA ligase activity(GO:0034841) thiophene-2-carboxylate-CoA ligase activity(GO:0034842) 2,4,4-trimethylpentanoate-CoA ligase activity(GO:0034865) cis-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity(GO:0034942) trans-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity(GO:0034943) branched-chain acyl-CoA synthetase (ADP-forming) activity(GO:0043759) aryl-CoA synthetase (ADP-forming) activity(GO:0043762) 3-hydroxypropionyl-CoA synthetase activity(GO:0043955) perillic acid:CoA ligase (ADP-forming) activity(GO:0052685) perillic acid:CoA ligase (AMP-forming) activity(GO:0052686) (3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (ADP-forming) activity(GO:0052687) (3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (AMP-forming) activity(GO:0052688) pristanate-CoA ligase activity(GO:0070251) malonyl-CoA synthetase activity(GO:0090409) |
0.1 | 0.2 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.1 | 0.2 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
0.1 | 0.1 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
0.1 | 0.1 | GO:0019862 | IgA binding(GO:0019862) |
0.1 | 0.4 | GO:0015266 | protein channel activity(GO:0015266) |
0.1 | 0.4 | GO:0031996 | thioesterase binding(GO:0031996) |
0.1 | 0.2 | GO:0034548 | N-cyclopropylmelamine deaminase activity(GO:0034547) N-cyclopropylammeline deaminase activity(GO:0034548) N-cyclopropylammelide alkylamino hydrolase activity(GO:0034549) 2,5-diamino-6-ribitylamino-4(3H)-pyrimidinone 5'-phosphate deaminase activity(GO:0043723) tRNA-specific adenosine-37 deaminase activity(GO:0043829) archaeal-specific GTP cyclohydrolase activity(GO:0044682) tRNA-specific adenosine-34 deaminase activity(GO:0052717) |
0.1 | 0.8 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.1 | 0.2 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
0.1 | 0.2 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.1 | 0.1 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
0.1 | 0.1 | GO:0002134 | UTP binding(GO:0002134) pyrimidine ribonucleoside binding(GO:0032551) |
0.1 | 0.2 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
0.1 | 0.7 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.1 | 0.2 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.0 | 1.5 | GO:0051723 | protein methylesterase activity(GO:0051723) |
0.0 | 0.0 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
0.0 | 2.0 | GO:0031072 | heat shock protein binding(GO:0031072) |
0.0 | 0.2 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.0 | 0.1 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
0.0 | 0.0 | GO:0008187 | poly-pyrimidine tract binding(GO:0008187) |
0.0 | 0.1 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
0.0 | 0.2 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.0 | 0.1 | GO:0097016 | L27 domain binding(GO:0097016) |
0.0 | 0.4 | GO:0032183 | SUMO binding(GO:0032183) |
0.0 | 1.0 | GO:0004027 | alcohol sulfotransferase activity(GO:0004027) |
0.0 | 0.2 | GO:0001595 | angiotensin receptor activity(GO:0001595) |
0.0 | 0.2 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
0.0 | 0.1 | GO:0015232 | heme transporter activity(GO:0015232) |
0.0 | 0.1 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.0 | 0.1 | GO:0015299 | solute:proton antiporter activity(GO:0015299) |
0.0 | 0.1 | GO:0002046 | opsin binding(GO:0002046) |
0.0 | 0.1 | GO:0050309 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.0 | 0.1 | GO:0038187 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
0.0 | 0.1 | GO:0032407 | MutSalpha complex binding(GO:0032407) |
0.0 | 0.5 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.0 | 0.0 | GO:0005148 | prolactin receptor binding(GO:0005148) |
0.0 | 0.1 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.0 | 0.1 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.0 | 0.8 | GO:0008528 | G-protein coupled peptide receptor activity(GO:0008528) |
0.0 | 0.9 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.0 | 0.0 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.0 | 0.1 | GO:0016668 | oxidoreductase activity, acting on a sulfur group of donors, NAD(P) as acceptor(GO:0016668) |
0.0 | 0.1 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.1 | 4.1 | PID S1P S1P2 PATHWAY | S1P2 pathway |
1.9 | 48.4 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
1.8 | 19.9 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
1.6 | 69.7 | NABA COLLAGENS | Genes encoding collagen proteins |
1.6 | 1.6 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
1.1 | 50.9 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
1.1 | 34.0 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
1.0 | 24.0 | PID EPHB FWD PATHWAY | EPHB forward signaling |
1.0 | 2.0 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
1.0 | 11.1 | PID ALK2 PATHWAY | ALK2 signaling events |
1.0 | 27.9 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
1.0 | 13.8 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.9 | 16.0 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.9 | 22.4 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.9 | 9.1 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.9 | 15.5 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.9 | 1.8 | PID S1P S1P3 PATHWAY | S1P3 pathway |
0.9 | 15.1 | PID ALK1 PATHWAY | ALK1 signaling events |
0.9 | 7.9 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.9 | 34.6 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.8 | 3.9 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.8 | 10.8 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.8 | 14.6 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.7 | 2.9 | PID ERBB1 RECEPTOR PROXIMAL PATHWAY | EGF receptor (ErbB1) signaling pathway |
0.7 | 5.1 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.7 | 0.7 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.7 | 100.5 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.7 | 6.3 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.7 | 11.7 | PID IGF1 PATHWAY | IGF1 pathway |
0.7 | 1.3 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.7 | 11.1 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.7 | 7.2 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.7 | 19.6 | PID BMP PATHWAY | BMP receptor signaling |
0.6 | 5.8 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.6 | 14.9 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.6 | 2.4 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.6 | 8.4 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.6 | 2.9 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.6 | 5.1 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.6 | 7.9 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.5 | 4.3 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.5 | 15.0 | PID FGF PATHWAY | FGF signaling pathway |
0.5 | 13.5 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.5 | 3.6 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
0.5 | 8.8 | PID ENDOTHELIN PATHWAY | Endothelins |
0.5 | 66.9 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.5 | 28.9 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.5 | 5.8 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.4 | 14.2 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.4 | 3.0 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.4 | 7.3 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.4 | 6.4 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.4 | 7.5 | PID RAS PATHWAY | Regulation of Ras family activation |
0.4 | 8.1 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.4 | 4.4 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.4 | 4.7 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.4 | 2.3 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.4 | 1.6 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.4 | 1.2 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.4 | 0.7 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.4 | 9.2 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.4 | 2.2 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.4 | 69.4 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.4 | 11.9 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.4 | 4.0 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.4 | 7.1 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.3 | 4.2 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.3 | 0.3 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.3 | 3.7 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.3 | 8.9 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.3 | 3.9 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.3 | 3.5 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.3 | 1.9 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.3 | 0.6 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.3 | 0.9 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.3 | 0.6 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.3 | 9.4 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.3 | 59.8 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.3 | 3.2 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.3 | 2.7 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.3 | 0.8 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.3 | 6.8 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.2 | 0.5 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.2 | 2.5 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.2 | 1.2 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.2 | 1.8 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.2 | 0.5 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.2 | 1.3 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.2 | 5.2 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.2 | 5.9 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.2 | 1.4 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.2 | 0.4 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.2 | 0.4 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.2 | 1.3 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.2 | 0.7 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.2 | 0.6 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.2 | 0.3 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.2 | 4.4 | PID NOTCH PATHWAY | Notch signaling pathway |
0.1 | 0.6 | PID EPO PATHWAY | EPO signaling pathway |
0.1 | 0.6 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.1 | 1.7 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.1 | 2.6 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.1 | 0.8 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.1 | 2.5 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.1 | 2.9 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.1 | 1.2 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.1 | 0.4 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.1 | 2.0 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.1 | 0.9 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.1 | 1.9 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.1 | 1.4 | PID AURORA A PATHWAY | Aurora A signaling |
0.1 | 6.8 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.1 | 0.3 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.1 | 0.5 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.1 | 1.4 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.1 | 0.7 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.1 | 0.2 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.0 | 0.2 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.0 | 0.1 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.0 | 0.1 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.0 | 0.1 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.0 | 0.1 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.0 | 0.3 | NABA CORE MATRISOME | Ensemble of genes encoding core extracellular matrix including ECM glycoproteins, collagens and proteoglycans |
0.0 | 0.1 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.0 | 82.3 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
2.1 | 4.3 | REACTOME FGFR2C LIGAND BINDING AND ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
1.6 | 18.0 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
1.5 | 33.8 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
1.5 | 19.4 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
1.5 | 78.5 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
1.4 | 1.4 | REACTOME NEF MEDIATES DOWN MODULATION OF CELL SURFACE RECEPTORS BY RECRUITING THEM TO CLATHRIN ADAPTERS | Genes involved in Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters |
1.3 | 26.3 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
1.1 | 14.8 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
1.1 | 21.5 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
1.1 | 6.7 | REACTOME THROMBOXANE SIGNALLING THROUGH TP RECEPTOR | Genes involved in Thromboxane signalling through TP receptor |
1.0 | 11.5 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
1.0 | 14.0 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.9 | 0.9 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.9 | 7.9 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.9 | 0.9 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.8 | 1.7 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
0.8 | 3.0 | REACTOME G BETA GAMMA SIGNALLING THROUGH PI3KGAMMA | Genes involved in G beta:gamma signalling through PI3Kgamma |
0.7 | 14.2 | REACTOME MUSCLE CONTRACTION | Genes involved in Muscle contraction |
0.7 | 9.7 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.7 | 6.8 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
0.7 | 10.3 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.7 | 6.8 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.7 | 2.0 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.7 | 2.7 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.7 | 12.5 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.6 | 0.6 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.6 | 8.2 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.6 | 5.0 | REACTOME OPSINS | Genes involved in Opsins |
0.6 | 16.9 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.6 | 16.6 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
0.6 | 4.7 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.6 | 5.1 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.6 | 1.1 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.5 | 6.0 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.5 | 23.4 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.5 | 20.4 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.5 | 2.0 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.5 | 0.5 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.5 | 4.5 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.5 | 41.7 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.5 | 1.5 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.5 | 4.0 | REACTOME RORA ACTIVATES CIRCADIAN EXPRESSION | Genes involved in RORA Activates Circadian Expression |
0.5 | 5.4 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.5 | 8.3 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.5 | 2.4 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.5 | 7.6 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.5 | 3.3 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.5 | 1.9 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.5 | 33.1 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.4 | 5.4 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.4 | 2.6 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.4 | 3.4 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.4 | 4.2 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.4 | 9.3 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.4 | 7.2 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.4 | 3.9 | REACTOME GRB2 EVENTS IN ERBB2 SIGNALING | Genes involved in GRB2 events in ERBB2 signaling |
0.4 | 10.9 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.4 | 8.8 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.4 | 7.2 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.4 | 18.0 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.4 | 17.9 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.4 | 2.5 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.4 | 2.8 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.3 | 9.7 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.3 | 5.7 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.3 | 9.3 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
0.3 | 2.2 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.3 | 3.5 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.3 | 3.7 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF RAS | Genes involved in CREB phosphorylation through the activation of Ras |
0.3 | 10.7 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.3 | 1.2 | REACTOME ARMS MEDIATED ACTIVATION | Genes involved in ARMS-mediated activation |
0.3 | 4.2 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.3 | 3.6 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.3 | 2.4 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.3 | 0.5 | REACTOME POST NMDA RECEPTOR ACTIVATION EVENTS | Genes involved in Post NMDA receptor activation events |
0.3 | 1.6 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.3 | 2.6 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.2 | 10.2 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.2 | 0.5 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.2 | 2.8 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.2 | 2.5 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.2 | 1.9 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.2 | 1.4 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.2 | 0.2 | REACTOME DOWNSTREAM SIGNALING EVENTS OF B CELL RECEPTOR BCR | Genes involved in Downstream Signaling Events Of B Cell Receptor (BCR) |
0.2 | 4.0 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.2 | 1.8 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.2 | 3.1 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
0.2 | 1.6 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.2 | 0.7 | REACTOME ACTIVATED POINT MUTANTS OF FGFR2 | Genes involved in Activated point mutants of FGFR2 |
0.2 | 2.5 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.2 | 1.2 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.2 | 4.9 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.2 | 0.8 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.2 | 1.4 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.1 | 1.0 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.1 | 3.0 | REACTOME KINESINS | Genes involved in Kinesins |
0.1 | 1.5 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.1 | 1.4 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.1 | 0.4 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.1 | 3.2 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.1 | 0.3 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.1 | 8.4 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.1 | 0.8 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.1 | 0.4 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
0.1 | 1.4 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.1 | 2.2 | REACTOME ACYL CHAIN REMODELLING OF PE | Genes involved in Acyl chain remodelling of PE |
0.1 | 0.8 | REACTOME MRNA PROCESSING | Genes involved in mRNA Processing |
0.1 | 0.4 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
0.1 | 1.0 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
0.1 | 3.7 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.1 | 3.0 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.1 | 0.1 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
0.1 | 0.3 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.1 | 3.4 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.1 | 14.4 | REACTOME CLASS A1 RHODOPSIN LIKE RECEPTORS | Genes involved in Class A/1 (Rhodopsin-like receptors) |
0.1 | 1.0 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.1 | 1.0 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.1 | 0.3 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.1 | 0.8 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.1 | 1.3 | REACTOME GENERIC TRANSCRIPTION PATHWAY | Genes involved in Generic Transcription Pathway |
0.0 | 0.9 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.0 | 0.2 | REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 |
0.0 | 0.6 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.0 | 0.1 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.0 | 0.2 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.0 | 0.2 | REACTOME REPAIR SYNTHESIS FOR GAP FILLING BY DNA POL IN TC NER | Genes involved in Repair synthesis for gap-filling by DNA polymerase in TC-NER |
0.0 | 0.1 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.0 | 0.2 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.0 | 0.2 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.0 | 0.4 | REACTOME G2 M CHECKPOINTS | Genes involved in G2/M Checkpoints |
0.0 | 0.1 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
0.0 | 0.0 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.0 | 0.0 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |